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Abstract
Exploring factors impacting veterans’ hypertension (HTN) control is essential in
reducing the common cardiovascular disease event of stroke, heart attack, chronic kidney
disease and mortality. The purpose of this study was to describe multidimensional
factors impacting veterans’ HTN control. Utilizing a descriptive, exploratory, crosssectional, retrospective, convenience sampling research design, 331 electronic medical
records in a VA dashboard data set were reviewed for men and women veterans between
the age 24 and 98 years (M=62, SD=13) in a Southern California Veterans Affair
primary care clinic from October 17, 2014 through October 17, 2016. Data were
analyzed by univariate, bivariate and multivariate statistics. The study found that selfreported medication adherence to antihypertensive drugs (p < .001) was an independent
predictor to veterans’ final systolic blood pressure. Future HTN control research may
focus on some theory-guided multidimensional determinants of patients’ adherence to
HTN treatments and HTN control outcomes fully, utilizing a consistent HTN definition
defined by JNC-7.
Keywords: factors impacting hypertension control, self-reported medication
adherence, veteran, systolic blood pressure
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Chapter 1: Overview
Background and Rational
Exploring factors impacting veterans’ hypertension (HTN) control is important in
reducing common cardiovascular disease events of stroke, heart attack, chronic kidney
disease and mortality. Despite decades of efforts by government agencies, researchers,
healthcare providers and patients to improve the rate of HTN control, it remains a major
public health challenge in the United States. Compared with a target HTN control goal of
61.2% set by Healthy People 2020 (Gillespie & Hurvitz, 2013), the overall HTN control
rate remains suboptimal at 51.8% (Nwankwo, Yoon, Burt, & Gu, 2013). Reasons for the
suboptimal HTN control rate are multifactorial and likely associated with the insufficient
and or inaccurate description of predictive factors impacting HTN control. Guided by the
seventh report of the Joint National Committee on prevention, detection, evaluation, and
treatment of high blood pressure (JNC-7, Chobanian et al., 2003), the purpose of this
study was to describe multidimensional factors impacting veterans’ HTN control.
Significance
This study was significant for the nursing profession for a couple of reasons.
First, the study added comprehensive new knowledge concerning the characteristics of
hypertensive veterans in the Southern California region to the scholarly nursing research
database. Second, the finding of self-reported medication adherence as a predictor
(p<0.001) may stimulate further nursing research toward exploring some theory-guided
multidimensional determinants of patients’ adherence to HTN treatments and HTN
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control outcomes fully, utilizing a consistent HTN definition defined by JNC-7 which
may in turn, lead to an improved data collection, quality healthcare outcome and cost
saving. Third, the study offered many insights into conducting a retrospective analysis
with a Veterans’ Affair (VA) dashboard data set in an EMR system that may help novice
researchers with this approach in the future.
Hypertension (HTN) Control Conceptual Framework
The conceptual framework guiding the study design was based upon the JNC-7
HTN management guideline (Chobanian et al., 2003). Although this guideline
approached the HTN-control challenge from four-domains (Domains 1 to 4, see Figure
1), an additional domain was added to illustrate the conceptualization of the HTN-control
issue within Domain 5 (see Figure 2). As such, the HTN control conceptual framework
consisted of five domains: prevention, detection, evaluation, treatment, and outcome.
This study focused on the relationship between seven dimensional independent variables
(IVs) and one dependent variable (DV) at a final point of EMR review within Domain 5.
The seven dimensions were (a) socio-demographic (e.g., age, sex, race, religion, branch
of military service, time of military service, education, disability rating, insurance/copay),
(b) lifestyle (e.g., tobacco, alcohol, DASH, exercise, caffeine, stress), (c) secondary HTN
(e.g., obstructive sleep apnea [OSA]), (d) comorbidity (e.g., diabetes mellitus [DM],
dyslipidemia, obesity [BMI]), (e) mental health disorder (e.g., major depressive disorder
[MDD], generalized anxiety disorder [GAD], post-traumatic stress disorder [PTSD]), (f)
medication (e.g., effectiveness, adherence, number of primary and cardiology clinic
visits, antihypertensive medication names and quantities based on BP drug class, number
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of all medication), (g) uncontrolled HTN-associated end organ damage (e.g., cerebral
vascular accident [CVA], transient ischemic attack [TIA], congestive heart failure [CHF],
coronary artery disease [CAD], myocardial infarction [MI], coronary artery bypass graft
[CABG], chronic kidney disease [CKD]). This framework was used primarily for
identifying key study variables and developing a standardized data collection instrument
(see Appendix A).
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1. HTN PREVENTION:
Stage-2 HTN f/u 2-4 x /yr.
Assess lifestyle, fear or concern,
V 15.81, med-effectiveness,
clinical inertia, K+, Cr 1-2/yr., lipid,
BS past 12-month
Advise weight↓, DASH, smoke
cessation, mod-alcohol, exercise
3-4 days/week & 40’ per session,
BP treatment & goal
Arrange BP f/u appointment

2. DETECTION:
Secondary HTN
OSA, drug-induced HTN,
primary aldosteronism,
renal artery stenosis,
pheochromocytoma,
coarctation of aorta,
pulmonary hypertension

5. HTN CONTROL OUTCOME VARIABLES
BP < 140/90 mmHg for 2 years
(a) Sociodemographic
(b) Lifestyle
(c) Secondary HTN
(d) Comorbidity
(e) Mental health
(f) Medication
(g) Uncontrolled BP

3.

EVALUATION:
BP Categories: <120/80, 120-139/80-89,
140-159/90-99, ≥160/100,
White coat, resistant HTN, orthostatic
hypotension
BMI Categories: 25-29.9, 30-34.9,
35-39.9, ≥ 40
WC: male ≥40 ‘’, female ≥35”
History: lifestyle, comorbidity, OSA,
understanding, acceptance of HTN
diagnosis, treatment plan commitment
PE: brain (dementia, CVA, TIA); heart
(CAD, MI, CABG, CHF); kidney (CKD); eye
(retinopathy); CAD
Lab: microalbuminuria, GFR<60

4. TREATMENT
BP Goal <140/90 mmHg
Advise lifestyle change, DASH
Monotherapy for Stage 1 HTN: ACEI,
ARB, BB, CCB
or
Combination-therapy for Stage 2
HTN: thiazide diuretic & ACEI, ARB,
BB, CCB
or
Compelling indicator- add other drug
class
LVH/CHF/MI/CAD/CABG, DM,
CKD (GFR<60) ml/min, CVA/TIA
Minority group
Arrange weight reduction program

Figure 1. Hypertension (HTN) Control Conceptual Framework (5-domaine)
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Age
Sex
Race/Ethnicity
Religion
Branch of service
Time of service
Education
Disability Rating
Insurance/Copay

Brain (CVA/TIA)
Heart (CHF/CAD/MI/CABG)
Kidney (CKD)

End Organ Damage

(g) Uncontrol HTN variable:
SBP ≥ 140 mmHg
Baseline ↔ Final

(f) Medication

Med-effectiveness
Med-adherence
Clinic visit
BP medication
All medication

Tobacco
Alcohol
DASH diet
Exercise
Caffeine
Stress

(a) Socio-demographic
variable

(b) Lifestyle

Controlled HTN (DV):
SBP < 140 mmHg
Baseline ↔ Final

(c) Secondary HTN
variable OSA/Steroid

(e) Mental health

MDD (PHQ-9)
GAD (GAD-7)
PTSD (PCL-M)

variable

(d) Comorbidity

DM/A1C
Dyslipidemia/HDL
Obesity/BMI

Figure 2. Hypertension (HTN) Control Conceptual Framework (5th-domaine)
Purpose Statement
The purpose of this study was to describe multidimensional factors impacting
veterans’ HTN control. In this descriptive, exploratory, cross-sectional, retrospective,
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convenient sampling of primary data, 331 EMRs in a VA dashboard data set were
reviewed for men and women veterans aged 24 and older with essential HTN in one
Southern California VA primary care clinic from October 17, 2014 through October 17,
2016. Data was analyzed utilizing univariate, bivariate, and multivariate statistics.
Research Aims and Questions
Aim # 1.
Describe the characteristics of hypertensive veterans in one Southern California
VA clinic from data collected during a period of October 17, 2014 through October 17,
2016.
Question # 1.
What were characteristics of hypertensive veterans in one Southern California VA
clinic for the seven dimensions of IVs from data collected during a period of October 17,
2014 through October 17, 2016?
Aim # 2.
Examine the relationships among the predictor variables of blood glucose level
(A1C), high-density lipoprotein (HDL), body mass index (BMI), total number of BP
medications prescribed, total number of clinic visits, baseline SBP and the outcome
variable of the final point SBP.
Question # 2a.
Which of the possible six predictor variables were included in an equation for
predicting veterans’ final point SBP?
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Question # 2b.
Does the obtained regression equation resulting from a subset of the six predictor
variables allow us to reliably predict veterans’ final point SBP?
Aim # 3.
Describe any significant association between and among non-normally distributed
IVs and the final SBP.
Question # 3.
Can status of veterans’ final SBP be correctly predicted from knowledge of A1C,
HDL, BMI, Baseline SBP?
Aim # 4.
Describe any relationships between categorical predictor variables (Yes/No) and
an outcome variable of final controlled (SBP < 140) or uncontrolled (SBP ≥140).
Question # 4.
What were the significant relationships between age (≥60/<60), race (Black/nonBlack), religion (yes/no), tobacco use (yes/no), alcohol use (yes/no), OSA (yes/no), DM
(yes/no), dyslipidemia (yes/no), BMI (≥30/<30), MDD (yes/no), GAD (yes/no), PTSD
(yes/no), medication adherence (yes/no), brain damage (yes/no), heart damage (yes/no),
CKD (yes/no) and final SBP (≥ 140/< 140)?
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Chapter 2: Review of the Relevant Literature
The purpose of this chapter is to conduct a comprehensive review of the research
literature relevant to key concepts of HTN control. The chapter begins with a critical
review of a JNC-7 guided study, an historic overview of JNC BP treatment goals, and
HTN prevalence and risk factors. Ultimately, a systematic review of the most up-to-date
research studies is presented in domains of HTN prevention, detection, evaluation,
treatment, and control outcomes. The chapter will conclude with a summary of major
themes based on the literature reviewed and will suggest how this study might further add
to the scholarly nursing literature.
JNC-7 as a Study Conceptual Framework
A search of the literature using the key terms conceptual framework and JNC-7
and hypertension and veteran was conducted in Academia Premier, CINAHL, Health
Source (Nursing/Academic Edition), and PsychInfo within the past 5 years to identify
peer-reviewed journal articles pertaining to articles that utilizes the JNC-7 as a conceptual
framework. This approach yielded 16 articles with non-veteran populations. After
screening the abstracts, only one article was found to be relevant to the focus of this study
and was reviewed with attention to its study design.
Koti and colleagues (2015) conducted a retrospective chart review to compare the
documented provision of HTN care against JNC-7 HTN treatment guidelines (Chobanian
et al., 2003). In this study, the JNC-7 was utilized to develop a 15-item instrument used
for EMR chart audits (Koti & Roetzbeim, 2015). The provision of HTN care was scored
per the instrument and included:
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1. Cardiovascular risk factor
2. Identification of BP goal
3. Communicating BP goal to patients verbally or in writing
4. Monotherapy for Stage I HTN
5. Combination therapy for Stage II HTN or Stage I HTN with comorbidity
6. Notation of uncontrolled HTN by healthcare providers (BP ≥140/90 mmHg)
7. Discussing lifestyle modification for ≥ 50% of encounter by providers
Within the past 12 months:
8. Fasting lipid panel
9. DM, CKD, albuminuria
10. Serum creatinine
11. Blood glucose
12. Hematocrit
13. Serum potassium
14. Serum calcium
15. Electrocardiogram (EKG) measured at any point in the past
The study sample of 150 cases included 83 women and 67 men (Mage = 64.7
years; SD = 12.7 years) and clinic visits (M = 4.5; SD = 2). The study reported HTNdetection rate (96.7%), drug treatment rate (97.7%), healthcare provider’s explicit
identification of BP goals (18.7%), communicating BP goal to patients (10.7%),
discussion about lifestyle modifications at > 50% of their visits (22.0%), and HTNlaboratory evaluation for CKD (68.8% - 96.7%), including serum creatinine, blood
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glucose, and potassium. The study also found that married patients received more
guideline-recommended care than unmarried patients (80.4% vs 74.4%, p <0.05) and
men received more guideline-recommended care than did women (80.7% vs 76.4%, p
<0.05%).
Strengths of the study.
The study design was conceptualized by JNC-7 and capable of addressing four
domains of HTN control issues. Koti and Roetzbeim (2015) provided innovation as
evidenced by the creation of JNC-7 blueprint instrument for systematic chart auditing.
The study incorporated clearly-defined inclusion and exclusion criteria. The broad age
spectrum of the study subjects (Mage = 64.7 years, SD = 12.7 years) was representative of
hypertensive populations.
Weaknesses of the study.
The developed scoring instrument was not psychometrically validated prior to its
application. Additionally, the instrument scores were altered multiple times creating a
threat to the instrument’s internal validity (Waltz, Strickland, & Lenz, 2010). The
practice of oversampling non-Hispanic Black and Hispanic patients to maximize
statistical power for the study created a risk for selection bias, another threat to internal
validity. With multiple concerns for validity, these study results should be viewed as less
credible.
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Knowledge gaps.
JNC guidelines are not mandatory for providers; few studies have utilized JNC as
a conceptual framework. Healthcare providers must exercise their own clinical
judgement when referring to this guideline (Chobanian et al., 2003).
Historic Overview of Joint National Committee (JNC) BP Treatment Goals
Understanding the rational of recent changes in BP treatment goals necessitated
an historical perspective. Studies by Ogihara et al. (2010) and the JATOS Study Group
(2008) cited by JNC-8 (James et al., 2013), supporting these changes. In 2014, the BP
treatment goal for the general population was changed for people age 60 years or older (<
150/90 mmHg; James et al., 2013), up from the previous goal (140/90 mmHg) found in
the guidelines of JNC-4 through JNC-7 (Chobanian et al., 2003; "JNC 4," 1988; Pogue,
Ellis, Michel, & Francis, 1996; Sheps, 1997). Although the increase in this threshold was
recommended based on Grade A, strong scientific evidence by JNC-8 (James et al.,
2013), it has not been without controversy among experts in the field. First, the use of a
various BP treatment goals has resulted in a variation of reported HTN prevalence and
control, even when evaluating the same dataset (Crim et al., 2012). Second, the increase
in the threshold for this new BP goal precluded previously-eligible hypertensive patients
from being eligible for care, potentially leading to negative health outcomes. Third, JNC
1 through JNC-7 guidelines were traditionally produced by the National Heart, Lung, and
Blood Institute every 4 to 6 years, but JNC-8 was authored by the American Medical
Association, whose guideline quality might be different (James et al., 2013). Therefore,
it was important to look at the evidence presented by JNC-8 to understand the rationale

12

behind this change in BP treatment goal. A title search in the Google Scholar database
aided in locating two original research articles cited by JNC-8.
Should SBP be decreased in hypertensive elders?
Oibara and colleagues (2010) conducted a prospective randomized clinical trial
(RCT) comparing the incidence of cardiovascular events between two groups of Japanese
patients. The strict group had a target SBP goal of less than 140 mmHg, while the
moderate group had a target SBP goal between 140 mmHg and 150 mmHg. The study
sample comprised outpatients, ages 70 to 85, either gender, with seated SBP at or above
160mmHg and DBP less than 90 mmHg at two-visits within 2 to 4 weeks, and on
antihypertensive drug therapy that could be converted to valsartan. Excluded from the
study were patients with secondary HTN, malignant HTN, seated SBP at or greater than
200 mmHg or DBP at or greater than 90 mmHg, history of CVA, MI in past 6-months,
planned or previous arterio-plastic surgery within 6 months of study, Stage-3 CHF or per
New York Heart Association (NYHA) criteria, severe aortic stenosis or valve disease,
atrial fibrillation (a-fib), atrial flutter, arrhythmia, renal dysfunction with serum creatinine
at or greater than 2 mg/dl, severe liver dysfunction, hypersensitivity to valsartan, or
subjects deemed inappropriate for study per the investigators’ discretion (Ogihara et al.,
2004). Utilizing a log-rank test, Kaplan-Meier, and Cox proportional hazard statistical
analysis model, this study found that rates of adverse events were 18.2% in strict group
vs. 17.9% in moderate group (p = .851), concluding that strict BP control with SBP
greater than 140 mmHg might not be associated to the prevention of cardiovascular
disease (CVD) as compared with moderate BP control (SBP ≥ 140 but < 150 mmHg).
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Strengths of the study.
This study addressed a clinically significant question (Figure 1). The study profile
was helpful with understanding participants’ flow. Sample size calculations were
present. Valsartan intervention, as well as primary and secondary end-point measures
were described sufficiently.
Weaknesses of the study.
The age of the research subjects (M = 76.1, SD = 4.1) was too homogenous
reducing its external validity, thereby making the results non-generalizable to populations
younger than 72 years of age. The major confounders of BMI and alcohol use were not
statistically controlled. Using this evidence as a rational to increase the threshold of the
SBP treatment goal for people over 50 years of age was not scientifically sound because
the study did not cover groups aged 50 years - 72 years, major confounders were not
considered and controlled for, and major differences exist between Japanese and
American cultures.
Knowledge gap.
An optimal SBP goal for people over age 50 remained unknown.
Assessing the optimal SBP treatment goal.
The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly
Hypertensive Patients (JATOS) Study Group conducted a RCT to assess optimal SBP in
Japan (JATOS Study Group, 2008). The study had two intervention groups with a target
treatment goal of SBP less than 140 mmHg in the strict treatment group and SBP at 140
mmHg - 160 mmHg in mild treatment group. Two randomly assigned study samples
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comprised of Japanese patients with essential HTN had a total of 2,212 subjects in strict
treatment group (40% men, 60% women) and 2,206 in mild treatment group (38% men,
62% women). Subjects were aged 65 to 85 years with persistent SBP at or above 160
mmHg, received either no drugs or the same drugs for 4 weeks, and efonidipine could
either be given additionally or substituted for one of the drugs received before study
entry. Exclusion criteria were participants with DBP at or greater than 120 mmHg,
secondary HTN, stroke, MI, angioplasty within past 6-month, angina requiring
hospitalization, CHF at or greater than Class 2 per NYHA, a-fib, dissecting aneurysm of
the aorta, occlusive arterial disease, hypertensive retinopathy, liver enzymes more than
double the respective upper limits, fasting blood sugar at or greater than 200 mg/dl or
A1C at or greater than 8 mg/dl, serum creatinine at or greater than 1.5 mg/dl, malignancy
or collagen disease, and those deemed unsuitable for study (JATOS Study Group, 2008).
The study found (a) the primary endpoint events (e.g., brain, heart, kidney)
occurred among 86 patients in both treatment groups; (b) the secondary endpoint events
(e.g., discontinuation of treatment due to adverse events) indicated that 54 patients died in
the strict-treatment group, compared with 42 patients in the mild treatment group; and (c)
rates of morbidity and mortality from the primary end-point and its components did not
differ significantly between the two treatment groups. Therefore, the study concluded
that there was no significant difference in outcomes between the strict treatment group
and mild treatment group (JATOS Study Group, 2008).
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Strengths of the study.
This study addressed a clinically significant question. As shown in Figure 1, the
flowchart depicting the allocation of subjects was well-defined. Sample size calculations
were present and clear. The efonidipine intervention as well as the primary and
secondary end-point measures were described sufficiently.
Weaknesses of the study.
The study was fundamentally flawed for the following reasons:
1. While the study has a strict and mild treatment groups, the RCT lacked a true
control arm, one without any drug intervention; therefore, an objective
comparison of the primary and secondary end events could not be. Comparisons
between the two intervention groups were made relative to each other by
manipulating the interventional efonidipine or additional drugs and the baseline
medication used in each group was not equivalent.
The RCT design lacked detailed description about (a) the randomization
allocation sequence (RAS) method in how RAS was generated, what mechanisms were
used to implement RAS, and the party generating the RAS; (b) the person(s) enrolling
participants; (c) the person(s) assigning participants to the intervention groups, (d) single
blinded as only investigators were blinded and no detail about how they were blinded,
what they were told about the study; (e) the exclusion criterion, “patients considered
unsuitable as subjects were also excluded” (JATOS Study Group, 2008, p. 2117)
increased the potential for selection bias, a threat to internal validity.
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2. There was absence of information about inter-rater reliability among all end-point
evaluators.
3. The sample characteristics did not include a mean and standard deviation for age
in the strict and mild treatment groups.
4. BMI for strict treatment group (M = 23.6, SD = 3.4) and mild treatment group (M
= 23.6, SD = 3.5) were non-generalizable to the population of the United States
where most M ±SD ≥ 30 ±4 is common based on 50 relevant articles reviewed.
5. Table 3 was missing evidence of significant p-values, making the results invalid.
In summary, this study had multiple internal and external validity concerns that
suggest the results might be untrustworthy. Changing national HTN-management
guidelines without strong evidence or rationale could present a disservice to the medical
and research community, potentially misleading stakeholders in the HTN-management
process.
Knowledge gap.
Optimal SBP as well as primary and secondary end-point events described by the
study could also be assessed through a systematic review of RCTs, nonrandomized trials,
and/or meta-analysis of studies on patient populations within the United States.
HTN Prevalence Rates and Risk Factors
HTN is known as a disease of industrial society; its prevalence is low among
hunters, herders, and traditional agricultural communities (Landsbergis, Dobson,
Koutsouras, & Schnall, 2013). Prevalence rates for HTN are essential in measuring the
benefits of prevention, detection, evaluation, and treatment. In 2010, the prevalence of
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HTN among the world’s adults aged 21-year or older (31.1%; 95% CI [30.0%, 32.2%]),
with high-income countries (28.5%; 95% CI [27.3%, 29.7%]) compared to low-or-middle
income countries (31.5%; 95% CI [30.2%, 32.9%]; Mills et al., 2016). From 2011 to
2014, an overall prevalence of HTN among United States adults aged 18-year or older
was 29.0%, was similar among men (30.0%) and women (28.1%), increased with age
(7.3% for 18-39-year-olds, 32.2% for 40-59-year-olds, 64.9% for 60 years or older), and
the controlled HTN rate was only 53% among adults aged 18-39 (Yoon, Fryar, & Carroll,
2015). From 2009 to 2012, an age-adjusted HTN prevalence among U.S. veteran men
was 34.4% (95% CI [29.9%, 39.2%]); 2.2% higher than civilian population (Fryar,
Herrick, Afoul, & Ogden, 2016). In fiscal year 2010, HTN prevalence among U.S.
veteran women aged 35-44-year-olds was 13%, 45-54-year-olds was 28%, and 55-64year-olds was 42% (Vimalananda et al., 2013). A systematic review and meta-analysis
found the prevalence of HTN among homeless adults in America was like the general
population (Bernstein, Meurer, Plumb, & Jackson, 2015).
A comparison of male veterans to male non-veterans in the United States from
2009 to 2012 revealed that the prevalence of obesity was higher among male veterans
(43% vs. 34%), yet similar in dyslipidemia (49%, 48%), diabetes (10% vs. 9%) and
smoking (33% vs. 30%; Fryar et al., 2016). In one study of almost 2 million veterans
aged 65 years or older, risk factors for CV multimorbidities of HTN, CAD, and
dyslipidemia were higher in men (37.4% vs. 22.0%); also reported were the prevalence of
HTN (85% men, 82% women), dyslipidemia (78% men, 72% women), and CAD (46%
men, 28% women; Steinman et al., 2012).
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A study by Fletcher et al. (2012) reported HTN control rates for veterans had
improved 3% per year, to 76.3% over the 10-year period from 2000 to 2010. However,
this study had major systematic biases. First, the definition of HTN (BP > 140/90 mmHg
vs. BP ≥ 140/90 mmHg) was biased toward a higher HTN control rate based on JNC-7
guideline (Chobanian et al., 2003). Second, the definition of hypertensive as 3 or more
days of elevated BP, rather than 2 or more days or 2 occasions, was biased toward a
higher HTN control rate based on JNC-7 guideline. Third, the exclusion criterion of
missing readings without reporting the percent of missing data was a potential risk for
bias toward a higher HTN control rate. These risks for bias could have resulted in an
inflated HTN control rate (76%) and was likely spurious considering the sample size
included 582,881 veterans with HTN and 260,924 without HTN. Therefore, the study
conclusion was invalid.
HTN Prevention Domain
A search of the literature using key terms hypertension, prevention, qualitative,
observational, longitudinal, cohort, quantitative, RCT, interventional, systematic review,
meta-analysis and veteran in the databases of Academia Premier, CINAHL plus with text,
Health Source: Nursing/ Academic Edition, Military, Google Scholar, and PsychInfo
within past 5 years was performed to identify peer-reviewed journal articles pertaining to
the HTN prevention domains within the framework. The search yielded 47 articles.
After reading through the abstracts, only two articles were relevant to the focus of this
study and they were selected for review. Additional articles were found from the
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reference list in the selected articles. The addition was older than 5 years, but deemed
relevant and are therefore included in this review.
HTN prevention strategy.
Schmid and colleagues (2009) conducted a qualitative study to extract themes of
the HTN prevention strategy among 28 hypertensive veterans with a history of stroke or
transient ischemic attack. Utilizing a mixed method design and a focus group interview
approach, this study identified themes of external support, medication adherence, routine
development, BP monitoring, and HTN risk factor management (e.g., heart healthy diet,
exercise, stress reduction), and take advantage of teachable moments.
Strength of the study.
(a) The study addressed an important issue with HTN prevention. (b)
Interviewing bias was decreased by utilizing three independent stroke researchers apart
from the moderator to review and transcribe interview data. This also increased the
validity of the study result.
Weakness of the study.
Risk for self-selection sampling bias might have existed. The small sample size
within one region might be a risk to external validity of the study results.
Knowledge gap.
Despite protentional methodological weaknesses, the results were consistent with
much of the evidence-based research on the JNC-7 (Chobanian et al., 2003).
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Barriers of adherence to antihypertensive drug therapy.
AlGhurair and colleagues (2012) reviewed 74 articles of patient’s self-reported
barriers to the adherence of antihypertensive medications based on survey instruments
with attention to their psychometric properties. Adherence was defined as “the extent to
which a person’s behavior correspond with agreed recommendations from a healthcare
provider” (Sabate, 2003, p. 3). The review found that most surveys addressed patientrelated adherence (76%). Other barriers included therapy (29%), healthcare system or
team (27%), socioeconomic (22%), and condition-related (8%) The review stated that the
Moriskey Medication Adherence scale (Morisky, Ang, Kardrousel-Wood, & Ward, 2008)
was the most commonly used instrument (69% of survey studies), but only 20 out of 70
(39%) had established reliability and validity evidence.
Strengths of the study.
(a) The review addressed self-reported barriers of adherence to antihypertensive
medication issue. (b) Both observational and experimental studies were included in the
study design. (c) Five major bibliographic databases were used to identify relevant
studies to be reviewed, likely encompassing all important studies. (d) Inclusion and
exclusion criteria were stated clearly. (e) The World Health Organization
Multidimensional Adherence Model was utilized to guide the study. (f) The tables were
clear and well organized. (g) The conclusions offered direction for future research.
Weakness of the study.
Adherence lacks a theory-based operational definition and linkage to healthcare
outcomes, including SBP/DBP.

21

Knowledge gap.
Future research should examine multidimensional adherence models to guide the
measurement of barriers to adherence of HTN treatment to help stakeholders appreciate
how to optimize treatments and reduce the burden of uncontrolled HTN. Most studies
were poor in quality as only 39% out of 20 surveyed had evidence of validity testing
(AlGhurair, Hughes, Simpson, & Guirguis, 2012).
Self-measured BP monitoring and BP control.
Uhlig and colleagues (2013) conducted a systematic review and meta-analysis to
summarize evidence of the effectiveness of self-measured BP monitoring (SMBP) in
adults with HTN. The review included 52 prospective comparative SMBP studies versus
usual care or an alternative SMBP intervention in persons with HTN and found that
SMBP, with or without additional support, lowered BP compared with usual care, but the
BP lowering benefits beyond 1 year was uncertain (Uhlig, Patel, Lp, Kitsios, & Balk,
2013).
Strengths of the study.
(a) The review addressed a clearly focused issue on the effectiveness of SMBP.
(b) Inclusion and exclusion criterion were clearly stated. (c) The databases searched were
broad enough to have included all important, relevant articles. (d) All articles included in
the review were evaluated for quality. (e) The numerical BP results were reported
appropriately with confidence intervals in two standalone tables.
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Weaknesses of the study.
Although JNC-7 recommended SMBP with validated BP devices, this practice
has not been popular for two reasons. First, most hypertensive individuals did not need
SMBP, except for patients with white coat syndrome, persistent HTN, or orthostatic
hypotension. Second, the accuracy of SMBP could not be guaranteed as most healthcare
providers were reluctant to document the results of SMBP as a part of the patient’s
medical record).
Knowledge gap.
The validity of SMBP has been uncertain and should be used only if clinically
indicated and at the clinician’s discretion.
HTN Detection Domain
A search of the literature using the key terms hypertension, detection, qualitative,
quantitative, RCT, cohort, systematic review, meta-analysis, secondary HTN, drug
induced, primary aldosteronism, renal artery stenosis, pheochromocytoma, coarctation of
aorta, thyroid and parathyroid disease in the databases of Academia Premier, CINAHL
plus with text, Health Source: Nursing/Academic Edition, Military, and PsychInfo within
the past 5 years was performed to identify peer-reviewed journal articles pertaining to the
HTN detection domain within the framework. The search yielded 138 articles. After
reading through the abstracts, only one article was relevant to the focus of this study. The
article was older than 5 years with smart-text search, but was deemed relevant and
therefore included in this review.
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Drug-Induced Hypertension
Handler (2003) provided an in-depth discussion on secondary HTN specific to
drug-induced HTN through a case study methodology. The case began with a history of
present illness (HPI); the patient was a 59-year-old female who presented in a HTN clinic
for persistent HTN (e.g., BP 180-200/80-110 mmHg between home and clinic for 6
months) in December 2001. Her past medical history (PMH) included 12 years of
controlled HTN on HCTZ monotherapy, clonidine, and/or Felodipine for 6 months with
no effect and Tylenol® for osteoarthritic knee pain. Her brother, a physician, prescribed
Celebrex® 200 mg QD for her knee pain; she also reported taking various herbal
medicines to enhance well-being. On physical exam (PE), she was an overweight female
with BP 182/94 mmHg, HR 100 beats/min., heart and lungs sound normal, and 1-2+
ankle edema were noted. Laboratory included a urine analysis negative for proteinuria
and a serum creatinine that was 1.2 mg/dl. The extent of polypharmacy was not
appreciated until she was asked to bring in her pill bottles, including all prescription and
over-the-counter medications. That is when it was discovered that she was taking
Celebrex® and an herbal supplement containing ginger root. Once she stopped taking
the Celebrex, her BP dropped to 138/86 at the 3-week follow-up appointment. Removal
of Felodipine led to a resolution of her ankle edema and palpitation. Clonidine was
tapered off subsequently.
Upon analysis, Handler (2003) linked two results from a meta-analysis that
explored the association between nonsteroidal anti-inflammatory drugs (NSAIDs) and
HTN among persons already on antihypertensive medications. One finding suggested
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NSAID-induced BP increased from “6.10 mm for Naproxen, 4.77 mm for Indomethacin,
2.86 for Piroxicam compared to 2.20 for Sulindac and -0.30 mm for Ibuprofen” (Pope,
Anderson, & Felson, 1993, p. 83). Another study reported an NSAID-induced BP
increase of 6.2 mm and that Sulindac affected BP the least amount (Johnson, Nguyen, &
Day, 1994). A greater risk for increased BP existed when patients took both NSAIDs and
prescribed β-blocker concomitantly (Handler, 2003). Mechanism of NSAID induced
HTN was associated with an “inhibition of synthesis of vasodilatory and natriuretic
prostaglandins” (p. 83). Ginger root was thought to have some anti-inflammatory effect.
The study concluded that high BP might occur with discontinuation of clonidine and/or
methyldopa. In addition, surveying patients about their store-bought supplements was
essential to ensure that patients were not inadvertently causing any secondary HTN.
Strengths of the study.
The study design was appropriate for addressing the NSAID-induced HTN issue.
In both studies, the setting and subjects were representative of hypertensive veterans.
The researcher clearly articulated his perspective, which was backed up by the data
collection methodology (e.g., PHI, PMH, PE). The method of data analysis was valid
when referring to findings from two previous meta-analyses. The result was relevant to
patients and providers in healthcare settings and was transferable.
Weaknesses of the study.
The study lacked a clearly stated research question (e.g., Could Celebrex and
ginger root induce HTN?).
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Knowledge gap.
Many drugs were listed as potential for drug induced HTN, only a few have
established case studies in the literature. More case studies are needed to establish solid
scientific background for other drugs listed in the literature.
HTN Evaluation Domain
A search of the literature using key terms hypertension, evaluation, qualitative,
observational, longitudinal, cohort, quantitative, RCT, interventional, systematic review,
meta-analysis and veteran in the databases of Academia Premier, CINAHL plus with text,
Health Source: Nursing/ Academic Edition, Military, Google Scholar, and PsychInfo
within past 5 years was performed to identify peer-reviewed journal articles pertaining to
the HTN evaluation domains within the framework. The search yielded 38 articles.
After reading through the abstracts, only a handful articles were relevant to the focus of
this study and they were selected for review. Additional articles were found from the
reference list in the selected articles. These additions were older than 5 years, but
deemed relevant and are therefore included in this review.
Longitudinal predictors of masked HTN.
Skårn and colleagues (2015) conducted a longitudinal study with 10-20 years’
follow-up to identify longitudinal predictors of masked HTN defined as normal clinic BP
and hypertensive out-of-office. The study was relevant because masked HTN could not
be revealed by routine office BP measurements but could still be associated with CVD
events. HTN was defined as an average office BP at or above 140/90 mmHg; ambulatory
HTN was defined as day time (06:00-22:00) SBP/DBP at or above 135/85 mmHg and at

26

night (22:00-06:00 hour) SBP/DBP at or above 120/70 mmHg; white-coat HTN was
defined as BP at or above 140/90 mmHg in the office but normal out-of-office; sustained
HTN was defined as BP at or above 140 mmHg both in the office and out-of-office
settings. The study design included 100 Scandinavian men (Mage = 22, SD = 1), healthy,
and not on any medications. Subjects were recruited while attending compulsory medical
screening at a military draft laboratory in Norway from 1991 to 2002; these readings
served as the baseline. From January 2012 through November 2013, 17 years later,
follow-up measurements were taken on subjects (Mage = 39, SD = 4). Predictor variables
included age, fasting blood sugar (FBS), total cholesterol, triglycerides, BMI, waist
circumference (WC), daily smokers, office SBP/DBP, ambulatory SBP/DBP, white coat
BP, persistent BP, HR, adrenaline at rest and during activity; data were collected by two
people at baseline. A physician performed follow-up data collection. The study found
that participants with high screening BP at baseline had a much higher likelihood of
having masked HTN at follow-up (40%) compared to men with low screening BP (OR =
4.8, 95% CI [1.7, 13.5], p < .05).
Strengths of the study.
(a) The abstract provided a concise summary of the main features of the report.
(b) The introduction provided the rationale and aims for the study. (c) All tables and
figures were clear, simple, and independent. (d) Key study variables were clearly
operationally defined. (e) An effort of more than 17 years for this longitudinal study has
been recognized and appreciated.
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Weaknesses of the study.
The cross-sectional study result was not transferable to patients in the United
States for several reasons. (a) Operational definitions of ambulatory and masked HTN
were inconsistent with JNC-7 HTN management guideline. (b) The study design lacked
a detailed description of follow-up method, the study mentioned that subjects were not on
any medications at baseline, yet omitted participants’ medication status at follow-up, and
the inter-rater reliability statistic was not addressed; however, two people were involved
in the data collection process at baseline posing threats to internal and external validity.
(c) There was only one follow-up measurement point in the rare longitudinal study;
results could have been different with two or more measurements. (d) There was no
power analysis for the statistical analyses used by the study. (e) Reliability and validity
of the Smart Diet instrument in the original study and within the study sample were
omitted, another threat to internal validity and ultimately could affect external validity.
(f) There was no table or description of how the researchers controlled for major
confounders (e.g., alcohol consumption, physical activity, diet, weight, BMI, medication)
at baseline and at the final point of data collection. Nevertheless, one could view the
introduction of masked BP as either a new challenge within the complex HTN control
research arena or an unremarkable phenomenon considering that HTN research has yet to
identify an optimal SBP for individuals with HTN.
Knowledge gap.
The associations between adolescent and adult BP in longitudinal studies is
needed as the literature on the topic is limited.
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Deep breathing: A test of the white coat effect.
Tomičić and colleagues (2015) conducted a controlled clinical trial to evaluate the
reliability of a deep breathing test to detect the white coat HTN phenomenon. The study
sample consisted of hypertensive men and women who were age and gender stratified;
106 subjects from 53-72 years old in the intervention group and 108 subjects from 59-72
years old in the control group. Data were collected during outpatient visits. The control
group had standard BP measurements and the intervention group had BP readings done
after 30 seconds of slow, deep breathing for three or four cycles. Utilizing a receiver
operating characteristic (ROC) curve methodology, the study found slow, deep breathing
of 30 seconds for three or four cycles (DBT) was the best detection for white coat HTN.
DBT was associated with a 15% or more reduction in SBP with a sensitivity of 94%
(95% CI [72, 100]). A BP reduction of 8% or less could rule out white coat HTN with a
specificity 78.4% (95% CI [64%, 85.9%]).
Strengths of the study.
(a) The abstract precisely captured the features of the main study. (b) The study
design was helpful in advancing science on the topic.
Weaknesses of the study.
(a) The conclusions drawn were misleading as 78.4% specificity of the deep
breathing test does not meet a reliability standard of 90% for a clinical test (Rice, 2013).
(b) Deep breathing may cause hyperventilation-associated numbness and tingling,
dizziness sensations.
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Knowledge gap.
More innovative studies are needed to find a reliable clinical test to help
differentiate white coat HTN from resistant HTN in primary care settings.
Diagnosis and treatment of resistant HTN.
Waeber and colleagues (2014) published an article to discuss the issue of
diagnosing and treating resistant HTN. The authors cited multiple studies in forming
their conclusion that a systematic out of office BP recording by either 24-hour
ambulatory BP monitoring or self-measurement at home were necessary to properly
diagnose patient with resistant HTN (Waeber et al., 2014). For treating resistant HTN,
these authors recommended a triple-drug regimen to include diuretic, blocker of the
renin-angiotensin system, and calcium channel blocker to not only normalize BP, but to
regress target organ damage and delay cardiorenal complications. Several definitions of
terminology made by the author group were useful for HTN research. For example,
uncontrolled and resistant HTN were similar in the definition of BP (≥140/90 mmHg),
but differed by the number of antihypertensive drugs patients took to lower their BP. In
uncontrolled HTN, patients’ BP remained above 140/90 mmHg regardless of the type and
the number of antihypertensive agents taken, whereas in resistant HTN, patients’ BP
remained above 140/90 mmHg regardless of lifestyle measures and the concurrent use of
three antihypertensive agents belonging to different classes with all drugs being
prescribed at full dosage, including one diuretic (Waeber et al., 2014). Patients with
white coat HTN were resistant to antihypertensive treatment (BP ≥ 140/90 mmHg) in the
clinical setting, but normal when out of the office (Waeber et al., 2014).
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Strengths of the study.
The authors, consisted experts in the field, provided a candid discussion from
their review of the empirical literature.
Weaknesses of the study.
(a) This article was based on a literature review of original publications rather
than being an empirical study. (b) The definition of uncontrolled HTN could overlap
with the definition of resistant HTN; the number of antihypertensive drugs defined were
vague. (c) The concepts of uncontrolled HTN, resistant HTN, and white coat HTN were
similar in the context of HTN treatment and should be further developed. (d) The
measurement of 24-hour ambulatory BP is labor intensive and home BP monitoring is
potentially unreliable associated with calibration and or BP taking technique variabilities
and cheating, raising validity concerns.
Knowledge gap.
More studies are needed to evaluate any overlap in defining the concepts of
uncontrolled HTN, resistant HTN, and white coat HTN. In addition, more studies are
needed to evaluate a sufficient way to diagnose and treat resistant HTN utilizing a
behavior modification approach.
Orthostatic hypotension and orthostatic HTN.
Wecht and colleagues (2016) conducted a cross-sectional survey to investigate
rates of prevalence in orthostatic hypotension (OH) and orthostatic hypertension (OHTN)
and associated factors among U.S. veterans. A convenient sample of 286 veterans was
collected at an urban VA medical center. Exclusion criteria included veterans who were
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unable to stand for 10 consecutive minutes, had an illness, infection, or were pregnant at
the time of recruitment. Outcome measures included heart rate and BP, collected with an
automated sphygmomanometer BP cuff, and orthostatic symptoms were collected by a 6item, 10-point orthostatic hypotension symptom assessment (OHSA) scale (Wecht et al.,
2016). Utilizing univariate X2, ANOVA, binary logistic regression, and logit calculation
data analysis, this study reported that: (a) 14% of veteran participants had OH, 22% had
OHTN, and 64% had normal BP (control group); (b) an increased prevalence of OH and
OHTN among veterans with DM (27%) and HTN (63%); (c) veterans with OH were
older than the control group and were taking more antihypertensive drugs than the control
and OHTN groups; (d) the prevalence of OH increased with age, the OHTN was
comparable in young (20-30) and old (70+) veterans (17% vs. 19% respectively), the
severity of fatigue and dizziness increased in veterans with OH and OHTN compared to
the reference group.
Strengths of the study.
(a) The title captured the study phenomenon and population involved. (b) The
abstract provided a precise summary of the main features of the report. (c) The
introductory paragraph provided sufficient background information and rationale for
conducting the study and the purpose statement was clear. (d) Key study variables (e.g.,
OH, OHTN, orthostatic symptoms) were operationally defined. (e) Findings were
presented appropriately.
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Weaknesses of the study.
(a) The study design lacked detailed descriptions identifying who collected the
data, the data collection period, the type of clinic, the number of interviewers, and the
location of the interviews. While minor, these research design issues could create risks
for bias. (b) The omission of reliability and validity data about the original OHSA scale
with this type of study sample could pose a threat to internal and external validity. (c)
The article did not reveal the identity of the person(s) analyzing the data. (d) a power
analysis should have been included estimating the minimum required sample size. The
cross-sectional study results from a convenience sample (N = 286) without power
analysis at a single site presented concerns with validity and credibility.
Knowledge gap.
Tests for the reliability and validity of an OHSA scale with the study sample
could have been conducted with resulting indexes being reported; therefore, replicating
the study could correct this methodological weakness.
Patients’ evaluation of appropriateness of HTN management.
Morecroft and colleagues (2006) conducted a semi-structured interview to
evaluate the appropriateness of HTN management to extract attributes from patients’
perspectives. The purposeful sample of 28 patients (12 women, 16 men), ages ranging
from 20 to 78-year-olds (M = 59 years), with an average of 10 years of HTN treatment in
East England were selected for the study. Findings reported that all patients considered
their HTN management regimen appropriate with two attributes justifying their decision:
explicit and implicit. Explicit attributes were those consciously known by patients (e.g.,
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relationship with the General Practitioner [GP], lowering of the BP). Implicit attributes
were those not consciously known by patients, but inherently meaningful to them (e.g.,
anxiety with concern of treatment and diagnosis, explanation of consequences from HTN
treatment, choice with number of antihypertensive drugs, side effects experienced from
taking antihypertensive drugs). The study suggested that having patients evaluate the
appropriateness of their HTN treatment might be unsuitable as (a) patients might not be
familiar with the concept of appropriateness in terms of their prescribed HTN treatment,
(b) patients might not be knowledgeable of medical terminology, (c) patients might prefer
to rely on their GP to interpret BP readings as okay, as before, higher/lower rather than
taking personal responsibility.
Strengths of the study.
(a) The title suggested a phenomenon of patients’ evaluation of the
appropriateness of their HTN management using qualitative methodology. (b) The
abstract provided a concise summary of the main features of the report. (c) The
introductory paragraph provided sufficient background information with the rationale for
doing the study. (d) The research aims and questions were explicitly stated. (e)
Inclusion/exclusion criteria were appropriate. (f) The sample size was adequate for
saturation of the themes. (g) The data collection method and audiotaped interview time
(45-60 minutes) in patients’ homes were adequate. (h) The figures detailing the interview
questions, mind-map, and example of a pen portrait were helpful for readers to quickly
grasp key points. (i) Findings were detailed, organized, logical, and consistent; the
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quantitative findings were validated by member checking and were trustworthy. (j) The
discussion was thoughtful and conclusions were thought provoking.
Weaknesses of the study.
The plethora of interview questions could be burdensome for some patients, but
was not mentioned as a limitation.
Knowledge gap.
Additional similar studies should be conducted among VA patients and VA
healthcare providers to gain these perspectives both qualitatively and quantitatively.
Twenty-four-hour blood pressure variability.
Pengo and colleagues (2015) conducted a 24-hour observational study to analyze
the changes in 24-hour BP variability (BPV) in relation to determinants (e.g., age, sex,
medication, absolute BP, nocturnal fall) among patients with controlled and uncontrolled
BP. The justification for this study was based on the association between BPV, CV
events, and mortality without known determinants. BPV was defined as the fluctuation
of BP values among various measurements over a defined time that were influenced by
behavioral, environmental, and humoral factors as well as neural central reflex stimuli.
The study sample comprised 446 subjects (53% male, 47% female; Mage = 57, SD = 16),
with essential HTN but without secondary HTN, who were recruited at an HTN clinic in
Italy between December 2010 and March 2013. Outcome measures were 24-hour
ambulatory BP (AMBP), daytime SBP/DBP, night-time SBP/DBP, nocturnal fall,
dippers, non-dipper, extreme dippers, and 24-hour activity diary including time of meals,
bed rest or sleep, and awakening times. Utilizing t-tests, Χ2, Kruskal-Wallis test, Dunn’s
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multiple comparison test, and multiple linear regression, this study found (a) no
significant mean differences in BPV between subgroups with controlled and uncontrolled
BP; (b) 24-hour BPV significantly increased in patients with uncontrolled BP, especially
at night; (c) the number of antihypertensive drugs used was not a predictor for BPV in
patients with uncontrolled HTN; (d) more than 40% patients were incorrectly classified
as resistant HTN rather than BPV. The conclusion was that absolute BP, nocturnal BP
falls, and age were predictive of one’s BPV.
Strengths of the study.
(a) The study examined a novel phenomenon associated with HTN control. (b)
Reporting was concise. (c) Tables and figures were well organized and self-explanatory.
(d) The discussion included a detailed explanation of the findings and associations with
previous research studies.
Weaknesses of the study.
Study results were less credible for the following reasons. (a) The study design
lacked a detailed description in inclusion and exclusion criteria, data collection procedure
identifying who measured the 24-hour ambulatory BP and counted items in the 24-hour
diary, operational definitions of key study variables (e.g., controlled BP, uncontrolled BP,
absolute BP, resistant BP), power analysis to support the sample size. (b) The crosssectional study design with data collection in 24-hours, then analyzed retrospectively,
could result in over- or under-estimating relationships between predictors and outcome
variables.
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Knowledge gap.
This topic has been extensively studied for over 30 years. A systematic review or
meta-analysis investigating the association between BPV, CV events, and/or mortality
should be done to evaluate the significance of topic.
HTN Treatment Domain
A search of the literature using key terms hypertension, treatment, qualitative,
observational, longitudinal, cohort, quantitative, RCT, interventional, systematic review,
meta-analysis and veteran in the databases of Academia Premier, CINAHL plus with text,
Health Source: Nursing/ Academic Edition, Military, and PsychInfo within past 5 years
was performed to identify peer-reviewed journal articles pertaining to the HTN treatment
domains within the framework. The search yielded more than 200 articles. After reading
through the abstracts, only a handful articles were relevant to the focus of this study and
they were selected for review. Additional articles were found from the reference list in
the selected articles. These additions were older than 5 years, but deemed relevant and
are therefore included in this review.
DASH diet and body weight.
Soltani and colleagues (2016) conducted a systematic review and meta-analysis to
assess the effects of a dietary approach to stop HTN (DASH) on body weight and
composition among adults. The 13 reviewed articles were captured from the databases of
PubMed, EMBASE, Scopus, and Google Scholar through December 2015. This study
found that the DASH diet significantly reduced body weight by -1.42 kg/m2 (95% CI [-
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2.03, -0.82]), BMI by -0.42 kg/m2 (95% CI [-0.64, -0.20]) and waist circumference (WC)
by -1.05 cm (95% CI [-1.61, -0.49]) over a period of 8 weeks to 1 year.
Strengths of the study.
(a) The study addressed a clearly focused issue. (b) The search of four
bibliographic databases and inclusion of 13 articles adequately included important,
relevant articles assessing the effect of DASH on weight and body composition in adults.
(c) The table presentation was helpful for reviewers to grasp the study sample
characteristics quickly. (d) There was no publication bias per Begg’s and Egger’s tests.
(e) The results appeared to be in line with the JNC-7 guideline (Chobanian et al., 2003).
Weaknesses of the study.
Although the study reported a non-publication bias by funnel plotting, referring to
a figure, that figure was missing from the report.
Knowledge gap.
The omission of a figure illustrating funnel plots for non-publication bias was a
quality gap by the study. Replication of this study is necessary to confirm the study
result.
Body weight and blood pressure.
Neter and colleagues (2003) conducted a meta-analysis of RCTs to estimate the
effect of weight reduction on BP. A total of 25 RCTs published between 1966 and 2002
were included in the meta-analysis. This study found a net weight reduction of -5.1 kg
(95% CI [-6.03, -4.25]) by means of energy restriction and physical activity, reduced SBP
by -4.44 mmHg (95% CI [-5.93, -2.95]), and DBP by -3.57 mmHg (95% CI [-4.88, -
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2.25]). Significantly larger BP reduction were observed in populations with an average
weight loss of more than 5 kg when compared to populations with less weight loss both
for SBP (-6.63 mmHg, 95% CI [-8.43, -4.82] vs. -2.70 mmHg, 95% CI [-4.59, -0.81]) and
DBP (-5.12 mmHg, 95% CI [-6.48, -3.75] vs. -2.01 mmHg, 95% CI [-3.47, -0.54]). The
study concluded that weight reduction was important for HTN prevention and treatment.
Strengths of the study.
(a) The study addressed a significant HTN prevention and control issue in a
scientifically rigorous manner. (b) The data sources were all RCTs; theoretically more
reliable results when compared with non-RCTs.
Weaknesses of the study.
A risk of bias existed due to an extreme outlier indicated on the funnel plot of
SBP (p. 879) and the results of meta-analysis might have concluded otherwise without
the outlier article.
Knowledge gap.
(a) The relationship between weight reduction and BP, particularly beyond 1 year,
remined unknown. (b) HTN research needed evidence from longitudinal studies of the
relationship between weight reduction and BP with three to five observational time
intervals over 3 to 5 years of follow-up. (c) The meta-analysis needed to pull data from
longitudinal study greater than 2 years of weight reduction and BP change to be helpful
to the future HTN research.
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Sedentary behavior and blood pressure.
Lee and Wong (2015) conducted a systematic review and meta-analysis to
examine the association between time spent in sedentary behaviors and BP. The 31articles in the review were published from 2002 to 2014. Out of the 31-articles, 21 of the
studies (67.7%) used SBP and/or DBP as an outcome measure; those 21 studies reported
an association between sedentary behaviors and SBP (n = 14; 66.7%) or DBP (n = 11;
51.1%). Sedentary behavior was defined by energy expenditure (≤ 1.5 metabolic
equivalent task) while in a sitting or reclining posture. The study found that an additional
1 hour of time spent in sedentary behaviors per day was associated with an increase of
0.06 mmHg of SBP (N = 108,228; 95% CI [0.01, 0.11]; p = .01) and 0.20 mmHg of DBP
(N = 107,791; 95% CI [0.10, 0.29]; p < .001). The study concluded that self-reported
sedentary behavior was associated with BP elevation.
Strengths of the study.
(a) The title suggested the study phenomenon and identified the report as a
systematic review and meta-analysis. (b) The abstract provided a clear and precise
summary of the features of the study. (c) The introductory paragraph provided a clear
aim and study hypothesis. (4) There was no evidence of publication bias.
Weaknesses of the study.
A causal relationship of sedentary lifestyle on BP was not established.
Knowledge gap.
More longitudinal and RCT studies are needed to establish evidence of causal
relationships between sedentary behavior and BP.
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Effects of flaxseed consumption on blood pressure.
Khalesi and colleagues (2015) conducted a systematic review and meta-analysis
to assess the effects of flaxseed consumption on BP. Eleven RCT and non-RCT articles
were reviewed utilizing MEDLINE, CINAHL, and Cochrane Library Central published
through July 2014. This study found that flaxseed supplementation reduced SBP (-1.77
mmHg; 95% CI [-3.45, -0.09]; p = .04) and DBP (-1.58 mmHg; 95% CI [-2.64, –0.52]; p
= .003). When consuming whole flaxseed, the DBP reduction was significantly greater (1.93 mmHg; 95% CI [-3.65, -0.21]; p < .05); for durations of 12 week or longer, the DBP
reduction was even greater (-2.17 mmHg; 95% CI [-3.44, -.89]; p < .05). Conclusions
indicated that flaxseed consumption lowered BP slightly and the benefit was greater
when consumed as whole seed for 12 weeks or more.
Strengths of the study.
(a) The study title identified the report as a systematic review and meta-analysis
of controlled trials. (b) The abstract provided a precise summary of the study. (c) The
introductory paragraph included background information, a rationale for the review, and
study objectives. (d) The methodology included the review registration number
(CRD42014010248), eligibility criteria, inclusion/exclusion criteria, information sources,
search strategies, process of study selection, data extraction, and quality assessment
protocols. (e) Key variables were operationally defined based on JNC-7. (f) Figures and
tables were clear and independent. (g) Results were detailed showing each study’s
sample characteristics. (h) The risk for bias was low with Rosendal scores between 50%
and 93% (> 60% = excellent) for the selected articles. (i) Individual study results were
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displayed in a forest plot. (j) The review gave direction for future research. (k) The
review could serve as an exemplar of systematic review and meta-analysis.
Weaknesses of the study.
The duration of flaxseed consumption (3-48 weeks) was inadequate for evaluating
its long-term benefit (> 1 year) for SBP/DBP reduction.
Knowledge gap.
(a) Potential side effects of flaxseed supplement should be studied among VA and
non-VA populations. (b) Qualitative study is needed to explore the mechanisms of how
flaxseed influences changes in BP (Khalesi et al., 2015).
Meaning of antihypertensive drug therapy.
Hultgren and colleagues (2014) conducted a qualitative study examining the
meaning of antihypertensive drug therapy among hypertensive patients at a primary care
clinic in Western Sweden. The study sample consisted of a purposive sample of 10
subjects (N = 6 men, 39-68 years old, M = 50 years; n = 4 women, 51-66 years old, M =
59 years) with various occupational backgrounds and on HTN treatment from 1 1/2
months to 15 years. This study revealed that patients’ experience with antihypertensive
drug therapy was a process where attitudes and behaviors changed from resistance to
medication (e.g., worry, side effects, lack of autonomy), to rescue medication (e.g., desire
for life style changes), to normal medication (e.g., trust healthcare).
Strengths of the study.
(a) The articles revealed many words useful for instrument development (e.g.,
symptom, headache, dizziness, altered sensation, sexual impairment, side effect, dislike,
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fear, knowledge, attitude, accept or resist, stroke, brain bleeding, heart infarction, worry,
lack of autonomy or control, normal or perfect, confidence). (b) Information on
informants clarified the sample characteristics. (c) The model presented clarified the
themes developed by the study.
Weaknesses of the study.
(a) The description of the phenomenological study design did not include the time
needed to complete the study. (b) The claim of increased validity utilizing all three
authors in the analysis of data could not be confirmed without evidence of intercoder
agreement or cross-checking (Creswell, 2014). (c) The discussion section included new
ideas that would be more appropriate in the literature review. (d) The qualitative
generalizability of the study results may be limited to Swedish population rather than
U.S. veterans (Creswell, 2014).
Knowledge gap.
No studies have explored the meaning of antihypertensive drug therapy from the
perspective of U.S. veteran patients.
Meaning of adherence to antihypertensive drug treatment.
Lahdenperä and Kyngäs (2001) conducted a qualitative study to describe
hypertensive patients’ treatment compliance and its deeper meaning in terms of
“intention, activity, responsibility and collaboration” (p. 189). The study included 21
subjects, 9 males and 12 females (M = 46 years, range 32-63 years), who were diagnosed
with HTN, on either antihypertensive medication or no medication for 1 year with a
diagnosis of HTN for 12 to 18 months. Patients were recruited by telephone, based on
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the information from a previous study, and interviewed at either a municipal health care
center or a Department of Nursing Health Administration in Finland. The study revealed
four levels of compliance (i.e., subconscious, cognitive, action, attitudinal) and attitudes
toward HTN treatment (i.e., careless, serious, adjusted well, frustrated). The authors
recommended that healthcare professionals listen to patients’ various levels of
compliances and attitudes with regards to their HTN treatment.
Strengths of the study.
(a) The title suggested a phenomenon of compliance by hypertensive patients and
their attitudes toward their illness. (b) The abstract provided a concise summary of the
main features of the report. (c) The problem statement indicated that hypertensive
patients often did not have any symptoms, did not feel ill, did not see any reason to treat
themselves and provided the rationale to conduct this study. (d) The key concept of
compliance, defined as “patients work to maintain their health in accordance with health
regimens and in collaboration with healthcare professionals” (Lahdenpera & Kyngas,
2001, p. 190), emphasized that patients’ responsibility was consistent with the theory of
self-care agency (Renpenning & Taylor, 2003). (e) Inclusion and exclusion criteria were
appropriate. (f) Sample size seemed to be adequate to gain a saturation of themes; the
setting was appropriate. (g) The 45 to 60 minutes allowed for audiotaped interview was
adequate. (h) The patients’ definition of the nursing role was “not that of a partner in
care, but that of a provider of nursing services congruent with the patient’s identified
goals” (Lahdenpera & Kyngas, 2001, p. 193) was consistent with self-care deficit theory
(Renpenning & Taylor, 2003). (i) Consistent with the social learning theory (Bandura,
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1971), the levels of compliance and attitudes toward HTN treatments were validated by
the authors reviewing research materials multiple times and utilizing a two-phased
categorization data analysis approach, making it trustworthy and potentially useful in the
development of an adherence instrument in the future.
Weaknesses of the study.
Validity for the study could be further strengthened with triangulation.
Knowledge gap.
No qualitative study has elicited the meaning of adherence to antihypertensive
drug therapy from patients and primary healthcare providers’ perspectives within the VA
system; these studies would be important for instrument development in the future.
Family nurse practitioners’ experience with pre-HTN care.
Hernandez and Anderson (2012) conducted three-dimensional qualitative
inquiries to explore family nurse practitioners’ (FNP) experience of caring for pre-HTN
patients Interviewing eight FNPs, five males and three females with 4 months to 18 years
of practicing experience in urban, rural, and suburban areas. This study revealed that
caring for pre-HTN patients was a complex and multifaceted experience and three major
themes emerged: (a) FNPs often failed to address the pre-HTN condition due to a time
constraints, patients had other urgent health problems that needed to be addressed at that
visit, or lack of reimbursement for addressing pre-HTN due to insurance or lack of public
support; (b) FNPs experienced frustration and bewilderment with their role identity due
to a conflicting practice model (holistic vs. medical), FNPs practiced the medical model
almost exclusively because of reimbursement; (c) FNPs encouraged a bridging model of
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hope (e.g., ability to promote cardiovascular health by being a good listener, educator,
follow the JNC-7 guidelines) for pre-HTN patients despite multiple barriers (e.g., sense
of betrayal by patients who promised to follow lifestyle modifications, no-show for
follow up appointments); this frustration could be avoided by not addressing pre-HTN
issues with non-compliant patients.
Strengths of the study.
The result of the study was a powerful, well-written story. (a) The methodology
was appropriate for addressing the research goal. (b) The purposive sampling method
provided diverse FNP experts with rich narratives. (c) Data collection was completed in
30-90 minutes in a private, mutually-agreed upon location with semi-structured interview
method; an appropriate framework. (d) Results of this study were trustworthy; themes
were consistent with findings of similar qualitative studies.
Weaknesses of the study.
It would be better if this was a mixed study design in that the magnitude of
themes (e.g., patients’ refusal to discuss lifestyle modification, no show at HTN followup clinic) may be addressed simultaneously. HTN control research needs improved data
collection for precision in targeting the problem.
Knowledge gap.
No qualitative study of HTN detection with sample of VA patients or VA
healthcare providers could be found. Evidence suggests a sufficient lack of quantitative
study detecting associations between refusing lifestyle modifications and the magnitude
of no shows at follow-up with SBP and/or DBP.
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HTN Control Domain
A search of the literature was performed utilizing the databases of Academia
Premier, CINAHL plus with text, Health Source: Nursing / Academic Edition, Google
Scholar, and PsychInfo within past 5 years to identify peer-reviewed journal articles
pertaining to the domain of HTN control. Key terms included hypertension, control,
blood pressure, systolic, diastolic, BP, age, sex, race, ethnicity, religion, religiosity,
education, health literacy, disability, insurance, copay, socioeconomic, demographic,
tobacco, smoking, alcohol, DASH, exercise, caffeine, coffee, stress, job strain, OSA,
diabetes, A1C, dyslipidemia, HDL, obesity, BMI, depression, anxiety, PTSD,
antihypertensive, medication adherence, clinic visit, end organ damage, stroke, transient
ischemic attack, heart failure, coronary heart disease, myocardial infarction, CABG,
CKD, and veteran. This approach yielded from zero to over one hundred articles under
each category per the HTN control conceptual framework. After screening the abstracts,
a few articles with high level of relevancy were selected for review. Additional articles
were found from the reference list in the selected articles. These additions were older
than 5 years, but deemed relevant and are therefore included in this review.
Socio-demographic variables impacting HTN control.
Age and blood pressure.
Presently, no credible evidence could be found to suggest a statistically significant
association between age and BP utilizing either systematic review and/or meta-analysis.
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Sex and blood pressure.
No credible evidence showing a statistically significant sex differences in SBP or
DBP utilizing systematic review and/or meta-analysis.
Racial discrimination and HTN.
Dolezsar and colleagues (2014) conducted a comprehensive, systematic review to
examine the association between racial discrimination and HTN. Discrimination was
assessed utilizing three validated tools. In 44 articles averaging 742 participants per
study, evidence suggested a small, significant association between perceived
discrimination and HTN among hypertensive Black males with low education.
Strengths of the study.
(a) The title described the study phenomenon and identified the report as a
systematic review. (b) The abstract providing a concise summary. (c) The literature
review had adequate background information and rationale. (d) The study aim was
clearly stated. (e) Inclusion and exclusion criteria appeared to be appropriate. (f) Tables
and figures were well-defined. (7) Key study variables were operationalized.
Weaknesses of the study.
(a) The study lacked article synthesis (e.g., author’s name, year of publication,
population, sample size, instruments, scores, confounders, outcome measures). (b) The
study lacked an objective finding describing the measurable effect of racial
discrimination on SBP or DBP by mmHg. Methodological weaknesses yield less
credible study findings.
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Knowledge gap.
No credible evidence showing the mean office BP or 24-hour ambulatory BP
differences among diversional racial and ethnic groups can be found in the literature.
Religious service attendance and blood pressure.
Bell and colleagues (2012) conducted a descriptive, correlational, cross-sectional
study to examine the association between religious service attendance (RSA) and BP
among three ethnic groups. Utilizing survey data from the 1994 National Center for
Health Statistics, the study initially enrolled a total of 18,825 participants aged 20 or
older through home interviews and medical examinations. After excluding participants
who were pregnant, had a heart attack, CHF, CVA and those who failed to answer an
interview question regarding the frequency of RSA, 12,488 remained for the final data
analysis. Mean and proportional differences of RSA were compared utilizing t-tests and
X2 tests. Associations between RSA and HTN (yes/no), as well as SBP and DBP, were
examined through logistic regression modeling. The study found no relationship between
RSA and HTN among Mexican-Americans, and RSA was inversely associated to SBP
for all three ethnic groups (i.e., White, Black, Mexican-American), but more so for
Whites and Blacks when compared with Mexican-Americans.
Strengths of the study.
The study addressed a sensitive yet important association between RSA and BP.
The abstract provided a balanced summary of how the study was conducted and the
research findings. The study utilized tables to explain the results, making it easier for
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readers to understand the statistical analyses performed in the study. The study provided
direction for future research on the topic.
Weakness of the study.
The study lacked clearly defined inclusion criteria and the design lacked a
detailed description of (a) relevant dates (e.g., beginning and end, length of time needed
to recruit 18,825 participants), (b) data collection procedures (e.g., who measured BP,
brand of BP equipment), (c) 34% attrition rate, (d) confounders (e.g., social support,
stress coping), (e) power analysis to justify N =12,488 for logistic regression model with
three IV (i.e., ethnicity, RSA, sex), a major threat to statistical conclusion validity. The
reported statistical method of t-test for mean SBP and DBP differences among 3-ethnic
groups, gender, and religious service attendance was questionable. A more appropriate
statistical analysis method should have been factorial multivariate analysis of covariance
(MANCOVA). If the author group conducted multiple t-tests, interpretation of the results
would be at a high risk for type I error. T-tests do not allow testing of interactions and
main effects, but were reported in the tables, thereby making the chance of a type I error
unlikely. Finally, the study oversimplified the complexity of religion study. It would
have been more meaningful had religion construct were multidimensional rather than
unidimensional as measured by church attendance only.
Knowledge gap.
Although much research has been conducted to examine relationships between
religion and HTN, most studies have major methodological weaknesses yielding findings
at high risk for bias. No systematic review or meta-analysis investigating the relationship
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between religious involvement and BP could be found. Per Gallup (2016), 70%
Americans identify as Christian; 53% reported that religion was very important in their
lives, suggesting a need to conduct research in this area. Further study is needed to
investigate the role of religion in BP control and/or HTN self-management as well as the
impact of religious involvement on BP changes among VA and non-VA population
comparison.
HTN education program and blood pressure.
Lauziere and colleagues (2013) conducted a quasi-experimental pilot study to
investigate changes in SBP and DBP associated with a HTN education program.
Participants were recruited from one physician’s office in Southeastern Canada between
September 2008 and December 2010. Participants were 20 to 70 years of age with HTN,
French-speaking, no prior exposure to HTN education (e.g., HTN risk factors), and
capable of participating in a HTN education program during the 6-month study. Patients
with DM, CVD, renal disease, and pregnancy were excluded from the study. IVs were
weight, BMI, WC, lifestyle (20-item instrument), quality of life (20-item instrument),
dietary habit (15-item instrument); DVs were SBP and DBP. Covariates or confounders
were age, number of years since diagnosis of HTN, gender, level of education, household
income, and employment status. Statistical methods employed by the study included (a)
t-tests and Fisher’s exact tests comparing the intervention and usual care group’s BP
differences, (b) MLR to assess the change of BP within the HTN education intervention
group from baseline to 6 months, (c) Poisson regression to assess change of physical
activity and knowledge scores before and after HTN education intervention, (d)
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polynomial logistic regressions to assess between group differences in smoking and
alcohol use over a follow-up period. The study found a significant reduction of SBP in
the intervention group compared with the regular care group (p < .05) without betweengroup differences in weight, BMI, WC, lifestyle, QOL, and dietary habits.
Strengths of the study.
The study title indicated the study design and HTN phenomenon. The abstract
provided a concise summary of the main features of the study report. The introductory
paragraph provided sufficient background and rationale for the study. The purpose
statement was well-defined and the methodology was described in detail.
Weaknesses of the study.
One obvious weakness of the study was the small sample size of the intervention
group (n = 21) and regular care group (n = 19), which narrowed options of statistical
analysis with MLR, Poisson regression, and LR models down to zero with five IVs.
Lack of power associated with small sample size could explain the negative finding of
between-group differences. Another weakness appears to be biased higher baseline
SBP/DBP in the intervention group compared with the regular care group, associated
with systematic sampling without blinding procedure, allowing for a significant reduction
in BP with medication therapy in the intervention group, not the usual care group. The
major confounder was not statistically controlled. Additionally, the 20-item-lifestyle, SF36 quality of life, and 15-item-dietary habits instruments were not validated before they
were used in the study. Finally, an intervention of 6 months was too short to be credible
for sustained effects on SBP and DBP changes.
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Knowledge gap.
The association between HTN education program and BP is limited.
Functional disability and blood pressure.
Qualitative study could reveal the phenomenon in which patients with functional
disabilities cannot open antihypertensive pill bottles, thereby affecting one’s BP control.
Quantitative study, however, has yet to associate this inability to one’s BP. There has
been no systematic review or meta-analysis on this topic.
Insurance expansion impact undiagnosed and uncontrolled HTN.
Hogan and colleagues (2015) conducted a secondary analysis utilizing data from
the 1999-2012 National Health and Nutrition Examination Survey to examine
associations between health insurance through the Affordable Care Act with the
diagnosis and management of DM, dyslipidemia, and HTN. The study sample consisted
28,157 adults aged 20 to 64 years (52% male); 6,366 were diagnosed with HTN and
1,531 with undiagnosed HTN. Uncontrolled HTN was operationally defined per JNC-7
guideline. Diagnosed HTN was operationally defined by a “yes” answer to the question
“have you ever been told by a doctor that you had high blood pressure?” (Hogan et al.,
2015, p. 1555). Utilizing an epidemiologic data analysis strategy, this study found
having health insurance was associated with a 9% higher probability of having a HTN
diagnosis compared with uninsured people and insurance was associated with lower SBP
(-2.9 mmHg) then people without insurance. IRB oversight and approval was done by
the National Center for Health Statistics. The work was supported by the National
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Institute of Diabetes and Digestive and Kidney Diseases (Grant No. 1R01 DK090435)
and the first author was a member of the World Health Organization.
Strength of the study.
The abstract provided a precise summary of the features in the study report. The
study methodology was described in detail. The statistical analysis method that utilized
Mahalanobis’ distance to match variables for reducing potential confounders and match
propensity scores for reducing risks of systematic sampling bias. Confounders were
statically controlled. Sensitivity analysis separated private insurance from ACA coverage
or non-insurance. Results were appropriately represented.
Weakness of the study.
There was no power analysis to justify the sample size (N = 28,157) for the MLR
model with four IVs (i.e., controlled HTN, uncontrolled HTN, A1C, total cholesterol), a
threat to statistical analysis validity. The SBP difference between insured to uninsured
cases could be clinically irrelevant.
Knowledge gap.
No knowledge gap; however, there is a need for risk-benefit analysis associated
with treating elders at BP goal (140/90 mmHg). There is also a need to analyze the
benefit of treating pre-HTN and conduct a cost analysis associated with pre-HTN
treatment (Moise et al., 2015).
Copayment and medication adherence.
Sinnott and colleague (2013) conducted a systematic review and meta-analysis to
quantify the risk of medication non-adherence in publicly insured populations with
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copayments. This is relevant because adherence to antihypertensive medication has been
associated to HTN-treatment success in RCT (Alhalaiqa, Deane, Nawafleh, Clark, &
Gray, 2012). The analysis comprised four studies of Medicare insurance plans and three
studies of copayment increase in the VA healthcare system in older men and women (M
= 72 years, Range = 65-85 years) with copayments from $5-7$. This study found
significant evidence of non-adherence to medicines among Medicare and VA insured
beneficiaries where copayments for medications were necessary (OR = 1.11, 95% CI
[1.09, 1.14], p < .001).
Strength of the study.
(a) The study title was a systematic review and meta-analysis. (b) The abstract
provided a concise summary of the features in the study report. (c) The methodology that
covered detailed eligibility criteria, information sources, search strategies, study
selection, data collection processes, summary measures, synthesis of results, and risk of
bias across studies. (d) Results were detailed and appropriate. (e) The discussion was
detailed, balanced, and candid. (g) The study resulted in important policy implications,
was trustworthy, and was relevant to the veterans’ population.
Weakness of the study.
No major validity concerns could be seen.
Knowledge gap.
A new knowledge gap was identified with this systematic review and metaanalysis: the association between socioeconomic status and non-adherence to
antihypertensive drugs was likely due to the lack of comprehensive socioeconomic

55

measures (Alsabbagh et al., 2014). To fill this gap, research for HTN control should
collect actual income and copayment data rather than nominal or ordinal data as HTN has
a higher prevalence in low-to-moderate socioeconomic groups.
Lifestyle as a variable impacting veterans’ HTN control.
Smoking and arterial stiffness.
Scallan and colleagues (2010) conducted a systematic review to assess a
combined effect of HTN and smoking on arterial stiffness, considering the role of large
arteries in the circulation of blood to the periphery. In the study reviewing four articles
published between 1985 and 2008 in English, HTN and smoking were independent
detrimental factors for raising arterial stiffness; the combined effects were even greater.
Strengths of the study.
(a) The study addressed a public health concern. (b) The introductory paragraph
provided sufficient background information and rationale for the review. (c) Inclusion
criteria were clear and strict, decreasing the risk for biased outcomes. (d) Figures and
tables stood alone. (e) The study reviewed both the acute and chronic effects of smoking
on arterial stiffness. (f) Major confounders were statistically controlled in addition to
strict inclusion criteria. (g) Conclusions included the need for future research.
Weaknesses of the study.
(a) The study title did not identify the report as a systematic review. (b) The
abstract lacked description of the data source and study participants. (c) The efforts from
following up the reference lists, personal contacts with experts, searching for unpublished
and non-English language studies were not evident in ensuring that all important and
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relevant studies were included. (d) The four articles reviewed were all cross-sectional;
the study would have been stronger if at least one RCT article were included in the
review. (e) The study lacked evidence of assessing individual article quality and overall
publishing bias. Higher quality systematic review and/or meta-analysis on the topic
would improve trustworthiness.
Knowledge gap.
Study is needed to examine smoking cessation therapy combined with the
appropriate antihypertensive medication for greater improvement of arterial stiffness
among veteran smokers with HTN.
Smoking and blood pressure.
Despite smoking being listed as an independent risk factor of essential HTN by
multiple JNC guidelines, no systematic review or meta-analysis has examined the
association between smoking and BP among any population in the literature. Existing
studies were primarily cross-sectional surveys; major findings supported the notion that
smoking or chewing tobacco affected BP (Hughes, Leong, Sothy, Lun, & Yed, 1993) or
did not affect BP (Li, Tong, Wang, Lin, & Zhang, 2010; Pandey, Shreevastva, &
Neupane, 2014; Thuy et al., 2010). Few interventional or longitudinal studies on this
topic could be found in scientific literature.
Alcohol and blood pressure.
Briasoulis and colleagues (2012) conducted a systematic review and metaanalysis to determine the effects of dose-response alcohol consumption on the long-term
risks of developing HTN among non-veteran men and women. A total of 16 prospective
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studies (N = 33,904 men) were chosen from the databases of MEDLINE, PubMed,
Embase, and Cochrane Library for Central Register of Clinical Trials (Briasoulis et al.,
2012). This study found a dose-response alcohol consumption between 10 gm /day and
11-20 gm /day tended to increase the risk of HTN (RR = 1.03, 95% CI [0.94, 1.13], p
= .51; RR = 1.15, 95% CI [0.99, .33], p = .06, respectively) and that heavy drinkers (3140 gm/day) was significantly associated with an increased risk of HTN (RR = 1.77, 95%
CI [1.39, 2.26], p < .001).
Strength of the study.
(a) The study addressed a clearly-focused dose-response alcohol consumption and
HTN risk. (b) The bibliographic databases used were credible and inclusive of all
important studies. (c) Inclusion and exclusion criteria were included. (d) A quality
assessment of all included studies was performed. (e) The authors of reviewed studies
were contacted if data was unclear; publication biases were checked and found to be low
risk. (f) Findings were presented with odds ratio and 95% CI, precise, and valid
including consistency with several prior studies.
Weakness of the study.
(a) The inclusion of studies using 160/95 mmHg as HTN definition reduced the
number of HTN cases, biasing results away from the null hypothesis; a threat to internal
validity. (b) Measuring alcohol consumption by grams per day was less common than
drinks per day; however, it is a more accurate measure. The study results are less
credible due to the HTN definition; not consistent with JNC guidelines.
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Knowledge gap.
(a) Excessive alcohol consumption and alcohol withdraw could raise BP and HR
significantly in patients going through alcohol overdose and detox. (b) There is a lack of
consensus for measuring alcohol consumption in terms of units.
DASH diet and blood pressure.
Saneei and colleagues (2014) conducted a systematic review and meta-analysis of
17 RCTs with 2,561 participants to assess the magnitude of the DASH diet on adults’ BP.
This study reported that the DASH diet significantly reduced SBP by 6.74 mmHg (95%
CI [-8.25, –5.23], I2 = 78.1%), DBP by 3.54 mmHg (95% CI [-4.29, -2.79], I2 = 56.7%)
with the mean baseline SBP and DBP explaining 24% and 49% of the variance among
the studies.
Strengths of the study.
(a) The abstract summarized the main features of the study. (b) The literature
review provided sufficient background knowledge, rationale, and aims for the review. (c)
The study followed a preferred reporting for systematic review and meta-analysis
(PRISMA) protocol. (d) Inclusion and exclusion criteria were clearly elucidated. (e)
Multiple databases were searched and the searching strategy was described clearly. (f)
Figures and tables were clear and distinct. (g) The risk of publication bias was checked.
(h) Results contributed significantly to HTN research databases.
Weaknesses of the study.
Minimal risks for bias or threats to validity were found in the study.
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Knowledge gap.
None could be identified.
Physical activity and blood pressure.
Semlitsch and colleagues (2013) conducted a systematic review and meta-analysis
to evaluate the long-term effects of increasing physical activity comparing with no
activity in adults with essential HTN. Outcome measures were all causes of mortality,
cardiovascular morbidity and mortality, end stage renal disease, quality of life, and
adverse events. This study has included three high-quality, systematic reviews published
between 1997 and 2009. Additionally, included were nine RCTs with at least 24 weeks
of follow-up evaluation for the effects of increased physical activity on BP among adults,
published by September 2012. This study was unable to form definitive conclusions
regarding the effects of increasing physical exercise on BP because of the following
limitations: (a) 50% of the included RCTs had small sample sizes, approximately 20
participants per group; (b) more than two-thirds of the studies included RCTs found to be
at high risk for bias.
Strengths of the study.
(a) The abstract provided a concise summary of the main features of the report.
(b) Utilized traditional methodology without deviation from the standards for a
systematic review and meta-analysis. (c) The presentation of results included tables that
were of sufficient detail and quality. (d) Discussion was thorough, balanced, and candid.
(e) Conclusions offered direction for future research.
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Weaknesses of the study.
Minimal risks for bias or threats to validity were found in the study.
Knowledge gap.
Figures illustrated that high quality studies were rare; approximately 99% of
studies were low in quality. Nonetheless, the effects of increasing physical activity on
BP reduction among hypertensive individuals remained unknown. High quality RCTs
are needed with large sample sizes to exam the effects of physical exercises on CV risks
and benefits among hypertensive individuals.
Coffee, blood pressure, and cardiovascular disease risk.
Mesas and colleagues (2011) conducted a systematic review and meta-analysis to
assess (a) the acute and long-term effect of caffeine and coffee intake on BP and (b) the
association between habitual coffee consumption and risk of cardiovascular disease
among hypertensive individuals. The study included five trials examining the acute
effects of caffeine on BP, three trials exploring the long-term effects of coffee intake on
BP, and seven cohort studies investigating the association between habitual coffee
consumption and cardiovascular events, all published by April 2011. The study
concluded that caffeine intake produced an acute increase in BP for 3 hours or more, but
there were no association between long-term or habitual coffee consumption and an
increased BP or risk of cardiovascular disease in hypertensive individuals.
Strengths of the study.
(a) The abstract provided a precise summary of the features of the study report.
(b) The introductory paragraph provided sufficient background information and rationale
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for doing the study. (c) The study methodology followed PRISMA and MOOSE
protocol. (d) The key variable of HTN was operationally defined based on JNC-7
(Chobanian et al., 2003). (e) The figures and tables were clear and independent. (f)
Results were detailed and depicted each study sample’s characteristics for which data
were extracted. (g) The study had strong external validity with no publication bias, per
Begg’s funnel plot and Egger’s test. (h) The conclusion that coffee intake had no longterm effect on BP was consistent with the findings of another meta-analysis (Zhang, Hu,
Caballero, Appel, & Chen, 2011). (i) The study results included important practice
implications, suggesting that the practitioner ask about caffeine intake prior to measuring
the patient’s BP.
Weakness of the study.
(a) The unit of coffee intake in milligrams was uncommon in the literature and
difficult to measure in everyday experience. (b) Mechanisms of caffeine raising BP for 3
hours or more after ingestion (dose-response) was not elaborated further in the review.
Knowledge gap.
(a) The need to study the dose-response relationship between coffee intake and
BP increase among VA and non-VA patients is indicated. (b) The effects of coffee or
caffeine on the degree of BP control among hypertensive patients should include possible
variations in the type of antihypertensive medication (e.g., ACEI, CCB, BB) as such
evidence could help adapt recommendations about coffee consumption in hypertensive
patients.
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Job strain and ambulatory blood pressure.
Landsbergis and colleagues (2013) conducted a meta-analysis and systematic
review to assess the relationship between job strain and ambulatory BP. The study
reviewed 29 articles, including 22 cross-sectional, one case control, and three cohort
studies. This study found that a single exposure to job strain was associated with higher
work SBP (3.43 mmHg; 95% CI [2.02, 4.84]; p < .001; I2 = 62.3) and DBP (2.07 mmHg;
95% CI [1.17, 2.97]; p < .001; I2 = 42.3). Associations were stronger in men versus
women and in studies of broad-based populations with limited occupational variance; the
study suggested that job strain be assessed to reduce one’s CV risk.
Strengths of the study.
(a) The title identified the main study phenomenon, meta-analysis, and systematic
review. (b) The methodology followed traditional meta-analysis protocol as well as
being thorough and balanced. (c) The presentation of results was clear and precise. (d)
The discussion was fair and balanced. (e) Directions for future research were offered. (f)
The study result is trustworthy.
Weaknesses of the study.
The abstract was missing background, objective, data source, study eligibility
criteria, participants, intervention, study appraisal, and synthesis method.
Knowledge gap.
Multiple gaps exist based on suggestions by the authors.
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Secondary HTN impacting veterans’ HTN control.
Obstructive sleep apnea and systolic blood pressure.
Kong and colleagues (2016) conducted a systematic review and meta-analysis to
evaluate an association between markers of metabolic syndrome and OSA. A total of 10
articles in the review were the most up-to-date evidence published by the end of 2015.
This study found that patients without OSA had lower SBP compared with those who did
have OSA (pooled SMD = 0.56; 95% CI [0.40, 0.71]). The study also found that patients
with OSA had lower HDL (pooled SMD = -0.27; 95% CI [-0.38, -0.16]; p < .001) and
higher LDL (pooled SMD = 0.26; 95% CI [0.07, 0.45; p < .05). In addition, OSA was
associated with an increased triglyceride (pooled SMD = 0.26; 95% CI [0.07, 0.45]; p
< .05) and FBG (pooled SMD = 0.35; 95% CI [0.81, 0.53], p < .001). OSA was
significantly associated, not only with SBP elevation, but also four lab components (i.e.,
HDL, LDL, triglyceride, FBG) suggesting that OSA is associated with metabolic
syndrome.
Strengths of the study.
(a) The abstract described the features of the study report clearly and precisely.
(b) The introductory paragraph clearly described the rationale and objectives for the
review. (c) The study followed PRISMA protocol. (d) Sensitivity analysis demonstrated
good reliability in study results in the relationship between OSA and SBP without
publication bias. (e) Strong evidence was presented for the association between SBP and
OSA.
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Weaknesses of the study.
(a) There was a potential publication bias for the associations between OSA and
lab parameters. (b) The form and effect size of the association between OSA and SBP
were not analyzed, likely due to a small sample size.
Knowledge gap.
The relationship between SBP (< 140 mmHg, ≥140 mmHg) and a diagnosis of
OSA based on the ICD-9-CM code among veterans remains unknown.
HTN comorbidity impacting veterans’ HTN control.
Impact of exenatide (Byetta) on HgA1C, weight, and blood pressure.
Paul and colleagues (2012) conducted a post-hoc analysis to examine the synergy
between improved glycaemia, weight loss, and BP reduction in patients treated with
either exenatide (Byetta®) twice daily (BID) or once weekly (OW). Byetta® was
manufactured by AstraZeneca. The study sample consisted of 686 subjects (53% men;
Mage = 55 years, SD = 10; Mweight = 95 kg, SD = 20; MSBP/DBP = 130/79 mmHg, SD =
15/9; MHgA1C = 8.3%, SD = 11%) treated with exenatide QW (n = 541) or BID (n = 145)
over 26 weeks. Patients were divided into four groups at each visit by glycaemia and
weight response; those who failed to reduce both A1C and weight below weight means
became the reference group. The other three groups were A1C reduction, weight
reduction, and both A1C and weight reduction. Compared with the reference group, the
study reported a significant likelihood of improving SBP (< 130 mmHg) by 88%, 61%,
and 30% respectively. The likelihood of improving DBP (< 80 mmHg) was 63%, 45%,
and 13% respectively.
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Strengths of the study.
(a) The study explained mechanisms of action regarding the glucagon-like
peptide-1 (GLP-1) receptor agonist exenatide. (b) Tables helped the reader visualize
various data distributions among groups. (c) The study explained beneficial effects of
exenatide in weight reduction, reduced A1C, and reduced BP.
Weakness of the study.
(a) Exenatide has not been approved as a drug of choice by the U.S. Food and
Drug Administration (FDA) for its BP lowering effect. (b) The reference group, by its
design, appeared to be inappropriate as it reported exenatide more effective in the
reduction of A1C and weight, more so than a true control group with no exenatide
treatment; this could be misleading. (c) Exenatide had multiple side effects, was costly
for patients with no health insurance or high copayments as exenatide was classified as a
third-tier drug for the treatment of diabetes. (d) The likelihood of BP reduction was
poorly explained.
Knowledge gap.
There was no correlational study to examine the association between A1C and
SBP/DBP among veterans in the literature.
HDL and blood pressure.
There was no correlational study to examine the association between HDL and
SBP/DBP among veterans in the literature.
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Obesity (BMI ≥30) and blood pressure.
Neto and colleagues (2013) conducted a cross-sectional survey to evaluate
relationships among BMI, waist circumference, waist-hip ratio, waist stature ratio,
conicity index, body adiposity index and BP in northeastern Brazil. The study sample
consisted of 316 community-dwelling adults aged 60–105 years old (M = 74 years, SD
=10). This study found that BMI and the body adiposity index were significantly
associated with male HTN, suggesting these measures be used to screen HTN in the
elderly men.
Strengths of the study.
(a) Research was needed for this research question. (b) The purposive sampling
method was appropriate for the research questions asked. (c) The sample size was
adequate for the Poisson and AUROC model used by the study.
Weaknesses of the study.
(a) There was a lack of evidence ensuring BP data accuracy as 20 students were
used to collect the BP data. (b) The sensitivity (39.3%) and specificity (82.1%) of BMI
for detecting HTN did not meet the minimum standard for a clinical measure. (c)
Measurements of alcohol (i.e., ≥1 time/week or < 1 time /week) was not helpful in
evaluating its impact on BP due to metabolic turnaround time. The results would be
considered untrustworthy.
Knowledge gap.
The relationship between BMI and SBP is limited.
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BMI and BP in diverse populations.
Abayomi (2012) conducted a meta-analysis to examine the relationship between
BMI and SBP among diverse populations. The study found that the relationship between
BMI and SBP could be linear or curvilinear, and was dependent upon the statistical
models used. The study concluded that those relationships were weak among differing
populations and age was not a confounder in that relationship.
Strengths and weaknesses of the study.
This PhD student’s dissertation project was diligent and likely conducted under
the supervision of academic advisors. No major methodological weaknesses were found.
The study result was trustworthy.
Knowledge gap.
The relationship between BMI and SBP was weak, both linear and curvilinear,
depending upon the statistical models used; an interesting starting point for this topic.
Mental health disorder impacting veterans’ HTN control.
Depression and HTN.
A systematic review and meta-analysis found the prevalence rate of depression in
patients with HTN (26.8%; 95% CI [21%, 32.3%]; Li, Li, Chen, Chen, & Hu, 2015). A
second systematic review found that late-life depression, defined as a depressive illness
in people aged 60 years or older, was significantly associated with hypotension rather
than HTN (Briggs, Kenny, & Kennelly, 2016). There was no credible evidence showing
a relationship between depression-symptom severity and BP by systematic review or
meta-analysis.
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Anxiety and HTN.
Pan and colleagues (2015) conducted a systematic review and meta-analysis. A
total of 21 articles were reviewed as the most up-to-date evidence by November 2014.
The study found a significant association between anxiety and HTN (OR 1.18; 95% CI
[1.02, 1.37], p < .001) from analyzing 13 cross-sectional studies and 8-prospective
studies (adjusted HR 1.55; 95% CI [1.24, 1.9]; p < .001). This study concluded that
anxiety, as an independent risk factor for HTN, required early detection and treatment
among patients with essential HTN.
Strengths of the study.
(a) The study was a systematic review and meta-analysis. (b) The abstract
described the feature of the study report clearly and precisely. (c) The introductory
paragraph described the rationale and objective for the review clearly and adequately. (d)
The study following the PRISMA protocol. (e) There was a strong evidence of an
association between BP and anxiety. (f) The mechanisms of the relationship found by the
study were discussed in detail. (g) The study suggested to use DSM-IV (GAD-7) to
assess anxiety.
Weaknesses of the study.
(a) The study included only English- and Chinese-language articles and could
have influenced pooled results. (b) The study was unable to analyze raw data, limiting
adjustment to many of the factors at the granular level and ultimately could have
influenced pooled results. (c) Measurement instruments for anxiety differed among the
21 studies, potentially affecting the pooled results. As 13 of 21 studies were cross-
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sectional, pooling data could produce similar outcomes but be of questionable accuracy.
(d) Anxiety is a treatable disease; its impact on BP could be dynamic. Interpreting and
applying study results should be done with caution.
Knowledge gap.
It is important to explore the short-term and long-term effects of anxiety on HTN
in terms of BP, CV risk factor (e.g., age, smoking, alcohol, sedentary, diet), and endorgan damage (e.g., brain, heart, kidney).
PTSD and blood pressure.
Paulus and colleague (2013) conducted a retrospective EMR data analysis to
examine if patients with PTSD had higher SBP, DBP and HR compared with non-PTSD
patients, as well as a relationship between trauma exposure and BP within the Iowa City
VA Healthcare System. The study sample consisted of veterans with co-morbidities of
depression, mood disorder, anxiety, smoking, and/or substance abuse in men (MPTSD = 26
years, n = 88; Mnon-PTSD = 32 years, n = 98). The study found significant differences in
veterans in the PTSD group in DBP (M = 87.6, SD = 6.3) compared to the non-PTSD
group (M = 78.4, SD = 7.2; Cohen’s d = 1.36 [large]) and in SBP between the PTSD
group (M = 133.8, SD = 8.6) compared to the non-PTSD group (M = 122.3, SD = 9.6;
Cohen’s d = 1.27 [large]). This study also found that trauma-exposed patients without
PTSD had significantly higher BP than non-exposed ones.
Strengths of the study.
This study addressed an important topic.
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Weaknesses of the study.
(a) Major confounders (e.g., anxiety, antidepressants for patients with mood
disorder) were not statistically controlled, a major threat to PTSD construct validity. (b)
The study lacked explicit exclusion criteria, a threat to internal validity. (c) No power
analysis was reported to justify the sample size for the two-sample t-test and the
ANCOVA, a major threat to statistical validity. (d) Key concepts were not operationally
defined (e.g., PTSD by ICD-9-CM code, psychiatric medication, notes, trauma exposure),
a threat to internal validity. The combination of methodological weaknesses made the
study untrustworthy.
Knowledge gap.
There was no systematic review and/or meta-analysis to explore the relationship
between PTSD and SBP/DBP with the most up-to-date evidence.
Medication impacting veterans’ HTN control.
Effectiveness of antihypertensive medication.
Fretheim and colleagues (2012) conducted a systematic review and meta-analysis
to evaluate which antihypertensive medication class was the most effective in reducing
the incidence of CVD outcomes for healthy people at risk. Results from this study could
assist in developing clinical recommendations for a first-line drug choice to prevent CVD
supported by study findings. A total of 25 articles was reviewed with the most up-to-date
RCT evidence through February 2011. The study found no particular drug to be more
effective in reducing CVD risk than others and the meta-analysis concluded that there
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was little or no difference between commonly used blood pressure lowering medications
for primary prevention of CVD.
Strengths of the study.
(a) The study title suggested important HTN control phenomena as a systematic
review and meta-analysis. (b) The abstract captured the main features of the study report.
(c) The methodology followed traditional systematic review and meta-analysis protocol
with clear inclusion and exclusion criteria; the study was registered (PROSPERO
CRD42011001066). (d) Results included self-explanatory tables with narrative. (e)
Critique of prior studies was fair and balanced; the study’s own limitations were
discussed in detail.
Weaknesses of the study.
No major validity concerns could be identified.
Knowledge gap.
The results appeared to conflict with the drug treatment algorithm recommended
by JNC-7; however, the trustworthiness of this study is compelling.
Providers’ assessment of adherence and intensification of BP medication.
Meddings and colleagues (2012) conducted a cross-sectional survey to answer
two research questions: How often did providers correctly identify patients with poor
adherence to chronic BP medication? and, how often did providers intensify BP
medication regimen on patients with significant non-adherence issue when BP was
uncontrolled? The sample consisted of 92 primary care providers and 1,169 veterans (M
= 65 years, SD =11) from nine different VA facilities in three Midwestern states. Data
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was collected on BP, at the time of study enrollment via automated data sources;
medication adherence, from VA pharmacy records 1-year prior and 90-day postenrollment with refill history for antihypertensive medication classes; provider-survey
post patient visit; and demographic questionnaire post patient’s clinic visit. Medication
non-adherence was based on a gold standard of continuous multiple-interval gap (CMG),
where non-adherence was defined as 20% CMG or greater. The patient would be nonadherent if the medication was missed 1 in 5 doses or more on average. The study found
an overall poor correlation between providers’ assessment of a patient’s adherence and
the patient’s refill adherence (r = .18, p < .001; Kappa = .15). The study also found that
BP medications were not available for 20% or more days in medication non-adherence
patients. Providers characterized 37% of 211 patients as medication non-adherence.
Among 18 patients with non-adherence 50% or more of the time, the provider assessed
44% as non-adherence. Providers intensified antihypertensive medications in 451 of
patients (42%) regardless their medication adherence status.
Strengths of the study.
(a) This study addressed a clinically significant issue. (b) Data collection was
from multiple sites, increasing the external validity of study results. (c) Key variables
were operationally defined. (d) Missing data were imputed to prevent sampling bias. (e)
Figures and tables were clear and independent. (f) Sampling characteristics were like
hypertensive veterans in Southern California in terms of age and race. The study results
appeared trustworthy.
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Weaknesses of the study.
There was no power analysis presented to justify the sample size for the logistic
regression model employed by the study.
Knowledge gap.
The authors made multiple references for a need of a reliable, multidimensional
HTN treatment adherence instrument.
Number of doctor’s office visits and HTN control.
There were no correlational studies, systematic review, or meta-analysis to
explore the relationship between the number of doctor’s office visits and SBP/DBP.
Impact of antihypertensive drug therapy on cognitive decline and dementia.
Rouch and colleagues (2015) conducted a systematic review to examine all
published studies investigating the relationship between antihypertensive drug therapy
and cognitive decline or dementia). A total of 38 articles were included in the review
from 1990 to 2014. A quality assessment of all articles was conducted by Jadad criteria
(Pogue et al., 1996). The study concluded that antihypertensive drug therapy might
decrease the incidence and progression of cognitive decline, dementia, and Alzheimer’s
disease, specifically calcium channel blockers and renin-angiotensin system blockers.
Strengths of the study.
(a) The study addressed the effects of antihypertensive drug therapy on cognition,
dementia, and Alzheimer’s disease. (b) The flowchart for the systematic review clarified
the process of article selection. (c) The tables were helpful in reviewing relevant study
categories systematically. (d) The article discussed reasons for variations. (e) An

74

explanation of the mechanisms with dementia prevention in the discussion section was
extensive. (f) This study results were consistent with another meta-analysis, with one
exception: antihypertensive drug use did not decrease the risk of developing Alzheimer’s
disease, associated cognitive decline, or cognitive impairment (Chang-Quan et al., 2011).
Weaknesses of the study.
(a) There was a lack of homogeneity in all the reviewed articles across study
designs, patient populations, variables, duration of follow-up, and methodology quality
impacting the estimation of effect size. (b) Antihypertensive medication dosage varied
study-to-study and most studies did not address the medication adherence issue, creating
an issue with the reliability of study findings. The overall results lacked a definitive
conclusion.
Knowledge gap.
The effects of CCB and ACEI on cognitive function, dementia, and Alzheimer’s
disease with 5 years or greater follow up among veterans’ and non-veteran population
will be needed to confirm the study results.
Uncontrolled HTN impacting veterans’ quality of life.
Impact of non-adherence on end-organ damage.
Gosmanova and colleagues (2015) conducted a cohort study with an 8-year
follow-up to examine the association between ICD-9-CM code V 15.81 (non-adherence)
and end organ damage (EOD) involving the heart, brain, and/or kidneys among 312,489
veterans with newly diagnosed HTN. The study sample was obtained from a prior HTN
study by including patients with the diagnosis of HTN (baseline GFR ≥ 60 ml/min per
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1.73 m2), initiated on one or more antihypertensive drugs in the outpatient setting from
October 1, 2004 through September 30, 2006, based on VA pharmacy dispensation
records. Patients who used combined drug therapy, on α-blocker monotherapy and with
an ICD-9-CM code for CHF and tachyarrhythmia were excluded from the study.
Outcome data, including demographic, laboratory, SBP/DBP, and comorbidity, were
collected. Patients were divided into two groups (inadequate or < 80% vs. adequate or
≥80%) based on their adherence to antihypertensive drug as estimated by medication
possession ratio (MPR) per VA standard formula. Follow up for brain damage with
stroke by ICD-9-CM codes and Current Procedure Terminology (CPT) codes, heart
damage with coronary artery bypass grafting (CABG), CAD and percutaneous
angioplasty, and kidney damage with GFR, study found that ICD-9-CM code V 15.81
independently predicted the incidence of stroke, CAD, CKD, and end stage renal disease.
Strengths of the study.
The study addressed an association between V 15.81 code and EOD among
veterans with essential HTN. Major confounders were statistically controlled.
Weaknesses of the study.
There was no power analysis to justify the sample size for the Cox regression
analysis of five independent variables (i.e., GFR, CKD, ESRD, CAD, stroke) used by the
study, a major threat to statistical conclusion validity affecting the trustworthiness of the
results.
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Knowledge gap.
A high quality, longitudinal study of HTN-associated EOD of the brain, heart,
and/or kidney with quantitative measurements of medication adherence and BP at yearly
follow up intervals for 7 to 8 years is needed.
Summary
In summary, several major themes emerged. First, essential HTN control is a
multidimensional issue associated with (a) patients’ consumption of excessive amounts of
salt, alcohol, caffeine products (Briasoulis et al., 2012; Chobanian et al., 2003; Neter et
al., 2003, Soltani et al., 2016), flaxseed (Khalesi et al., 2015), and lack of physical
exercise (Lee & Wong, 2015), smoking related arterial stiffness (Scallan et al., 2010),
illness of anxiety (Pan et al., 2015), metabolic syndrome, obesity (Kong et al., 2016),
knowledge of HTN disease or HTN risk factor and external support (Lahdenperä &
Kyngäs, 2001; Schmid et al., 2009), (b) providers’ attitudes in following JNC-7
guideline, time constraints, frustration with patients’ refusal to comply with medical
advice and missing scheduled appointments, HTN treatment guideline regarding to BP
treatment goal, (c) environmental factors, including health insurance, copayment (Sinnott
et al., 2013), job stress (Landsbergis et al., 2013) and BP treatment goals per HTN
treatment guideline, (d) antihypertensive drug effectiveness and adherence (Hultgren et
al., 2014; Schmid et al., 2009) and (e) end organ damage including CVA, TIA, vascular
dementia, CHF, CAD, MI, CABG, and CKD. Second, HTN-control research remains in
an infancy stage as scientists continue to seek an optimal SBP goal for hypertensive
individuals despite decades of research (James et al., 2013). Third, HTN-control research

77

lacks a theory-based, operational definition of patients’ adherence to HTN-control
protocol and HTN control outcomes (e.g., BP, HR, BMI, WC, cholesterol values, blood
sugar values, kidney function values, CVA, TIA, CHF, CAD, MI, CKD, quality of life)
based on current HTN treatment guidelines. Fourth, much of the current HTN control
studies have serious methodological weakness with non-probability sampling and crosssectional observational study design as the most commonly used ones without any
theoretical or conceptual basis, producing less than credible and useful results. Fifth,
most results in systematic reviews and meta-analyses were based on RCTs that lasted less
than a year and requires more longitudinal RCTs in the future. Sixth, major knowledge
gaps remain about the association of family history in premature CVD and how that
affects offspring BP. Seventh, there is a lack of evidence in the associations between IVs
(e.g., age, sex, race, religion, A1C, HDL, BMI, MDD, GAD, PTSD) and a DV (SBP)
among veterans. The study was intended to address the multidimensional factors
impacting veterans’ HTN control to contribute to the scholarly nursing literature.
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1. What is known?
• DASH significantly reduced weight in 8-week to 1-year by -1.42 kg/m2 (95% CI,
-2.03 to -0.82), BMI -0.42 kg/m2 (95% CI, -0.64 to -0.20) & Waist Circumference
-1.05 cm (95% CI, -1.61 to -0.49).
• Weight reduction of -5.1 kg (95% CI, -6.03 to -4.25) reduced SBP by -4.44 mmHg
(95% CI, -5.93 to – 2.95) and DBP by -3.57 mmHg (95% CI, -4.88 to -2.25).
• Sedentary behavior per day was associated with 0.06 mmHg increase in (95% CI,
0.01-0.11, p<0.05) SBP and 0.20 mmHg (95% CI, 0.10-0.29, p<0.001) in DBP.
• DASH significantly reduced SBP by 6.74 mmHg (95% CI: -4.29 to – 2.79, I2 =
56.7%), DBP by 3.54 mmHg (95% CI: -4.29 to -2.79, I2 = 56.7%).
• Caffeine intake produces an acute increase in BP for ≥ 3 hours, but there were no
associations between long-term or habitual coffee consumption and HTN or CVD
risk.
• Patients without the OSA had a lower level of SBP compared with those who had it
(pooled SMD = 0.56, 95% CI, 0.40 to 0.71).
• Job strain is significantly associated with ambulatory BP.
• Anxiety is significantly associated with HTN.
• Alcohol consumption/AUDIT-C score is significantly associated with BP.
2.
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

What is unknown?
An optimal goal of SBP for patients with HTN.
The association between insurance copayment and number of hypertension visit.
The association between age and BP (forms and strengths).
Sex difference in risk of cardiovascular disease and mortality.
The association between racial discrimination and BP.
The association between religious involvement and BP.
The association between a HTN education program and BP.
The association between veterans’ functional ability and BP.
The association between adolescents’ BP and adults’ BP.
The association between number of cigarettes smoked today and BP today.
The association between number of years smoked and BP trend by years smoked
The association between chronic stress (job strain) and BP (office BP x 4).
The association between MDD/PHQ-9 score and BP.
The association between PTSD/PCL-M score and BP.
The association between GAD/GAD-7 score and BP.

3. What the study adds?
•
•
•

Characteristics of hypertensive veterans in a Southern California primary care clinic.
Self-reported medication adherence is an independent predictor for one’s SBP.
Many insights into conducting secondary analysis with electronic medical records
(EMRs) that may help novice researchers with this approach in the future.

Figure 3. What is known, unknown and what the study adds?
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Chapter 3: Methodology
This chapter presents research methodology including study design, setting,
sample, and source of data for the study. It also presents sampling method, data
collection procedure, sampling size with power analysis and statistical analysis
procedure. The conclusion addresses issues for the protection of human subjects.
Study Design
The study is a descriptive, exploratory, cross-sectional, retrospective, convenient
sampling of an EMR data set analysis. The design was approved by the researcher’s
dissertation committee for four reasons. First, laboratory data (i.e., A1C, HDL) cannot be
obtained by interview, survey questionnaire, or other observational methods. Second, it
reduces resources by utilizing a pre-existing data. Third, it is time efficient when the
needed information is readily available and easily found. Fourth, research questions are
in accordance with the protection of cases under study.
Study Setting
The study was conducted at a Southern California VA primary care clinic for
approximately one month from October 17, 2016 through November 15, 2016.
Sample and Source of Data
The study sample comprised U.S. veterans with essential HTN based on ICD-9CM code 401. Data used in this report were from a VA dashboard data set at a Southern
California VA primary care clinic between October 17, 20014 and October 17, 2016.
The data set was used by providers to identify and monitor veterans with chronic disease
(e.g., HTN) as a standard feature of the EMR in the VA.
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Inclusion criteria.
Men and women veterans of any race, 24-years-old and above with essential HTN
and multiple comorbidity, with or without antihypertensive drug therapy.
Exclusion criteria.
Missed a baseline or final point of BP measurement, or had an organ transplant
and on steroid drug therapy.
Sampling Method
A convenience sampling method was used as it entailed using the most readily
available data to answer study questions and achieve the study objective at the time of
data collection. More specifically, study cases already existed in an EMR dashboard at
the time of data collection.
Data Collection Procedure
1. An expedited Institution Review Board (IRB) was granted because the research
collected pre-existing data without any procedure involvement.
2. Study oversight was determined by IRB at the University of San Diego and the
Department of Veterans Affairs VA Healthcare System, California.
3. A data extraction instrument was created based on the HTN control conceptual
framework (see Appendix B).
4. Retrospective data was collected by the researcher utilizing Microsoft Excel, then
uploading the raw data set directly to IBM SPSS Version 24.
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5. The researchers carefully reviewed the cover sheet, problem list, medication list,
order list, providers’ notes, lab values, reports of BMI and BP measurement of the
EMR covering two years, from October 17, 2014 through October 17, 2016.
6. Data collection took place in a private office at a Southern California VA primary
care clinic began at 8:00 AM and ended 5:00 PM, Monday through Friday, from
October 17, 2016 through November 15, 2016.
7. All harvested data was pre-coded to protect veteran cases’ confidentiality.
8. The harvested data was then mailed to the researcher’s password-protected e-mail
account electronically and stored on a flash drive.
9. Data accuracy was to be ensured with a random check of 33% data by a nurse
practitioner who is blinded to the study with an acceptable accuracy of Cohen’s
Kappa ≥ 0.81.
Sample Size and Power Analysis
1. The minimum sample size was 97 for the multiple linear regression (MLR) model
employed by the study per a priori sample size calculator with effect size (r2) =
0.15, statistical power = 0.8, predictor variable = 6 (i.e., A1C, HDL, BMI, BP
medications, clinic visit, baseline SBP) and probability = 0.05 (Soper, n.d.).
2. The minimum sample size was 300 for a logistic regression model (LRM)
employed by the study based on 50 cases per IV principle (Polit, 2012). The
LRM was utilized to explore non-normally distributed IVs (i.e., A1C, HDL, BMI,
baseline SBP) associated with a dichotomous DV of veteran’s final SBP control.
3. The researcher completed data analysis under the supervision of a PhD. Professor.
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Record identified at Dash Board:
N = 331
4 Excluded (missing baseline SBP)
1 Excluded (kidney transplant, on steroid
therapy)
N = 326
Figure 4. Data selection flow chart
Data Analysis Procedure
1. Screen for missing data with all IVs and DVs, including age, race, religion,
tobacco use, alcohol use, OSA, DM, dyslipidemia, BMI, MDD, GAD, PTSD,
medication adherence, brain damage, heart damage, kidney damage, A1C, HDL,
number of BP med, number of clinic visits, baseline SBP, and final SBP.
2. Screen for outliers (Mahalanobis distance).
3. Determine if data transformation would be indicated.
4. Run descriptive statistics on all IVs and DVs. Show results by number and
percentage with nominal, ordinal, or categorical level of data. Show results by
mean (M), standard deviation (SD), median, and mode for continuous levels of
data.
5. Test assumption of multiple linear regression (MLR) model and run the test.
(1) Normality test: Histogram, box plots, skewness, kurtosis.
(2) Linearity: Create correlation matrix between IVs and DVs (bivariate
scatterplots).
(3) Homoscedasticity:
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(a) Tolerance statistics with all IVs’ indices < 0.1 indicates no
multicollinearity problem (Mertler & Vannatta, 2013).
(b) Variance inflation factor (VIF) for each predictor, where < 10 indicates no
multicollinearity problem (Mertler & Vannatta, 2013).
6. Major confounder of HTN control including BMI, Alcohol use, all medication
and diagnosis of anxiety will be statistically controlled in this study.
7. Test assumptions of LR model and run the test.
(1) No normality, linearity, equal variance requirement.
(2) Predictor variable can be continuous, scale, or dichotomous.
(3) All probability will be ranging from 0 – 1.
(4) Sensitive to multicollinearity relationships and outliers.
(5) The -2 Log Likelihood (goodness of fit test) index should be = 0, but no strict
adherence in LR statistical analysis (Mertler & Vannatta, 2013).
8. Run χ2 or Fisher’s exact test to represent effect size with Cramer’s V for relevant
variable associations with a 2 X 2 table.
(1) Sample size assumption: no more than 20% of the contingency cells have
expected values <5 (Blaikie, 2003).
(2) Expected frequency cannot be <1 (Blaikie, 2003).
(3) In case of assumptions will be violated, Fisher’s exact test would be used to
interpret the test result as appropriately.
(4) Sample size requirement: 10 x 2 x 2 = 40 (Blaikie, 2003).

84

9. Summarize and interpret the results, represents results with more tables or figures
as indicated.
10. Discuss the data analysis results with major limitations to the study.
Protection of Human Subjects
Informed consent was not needed as the study involved collecting information
that had already existed in an EMR dashboard e-database and the research presented no
more than a minimal risk of harm to the study subjects. The protection of human subjects
was ensured by the researcher throughout the study. Prior to data collection, the
researcher completed the National Institutes of Health (NIH) module on the protection of
research subjects to have a thorough understanding of the methods used to protect
research participants. The activities of the researcher were monitored by the research
committee chairperson. The raw data will be stored in a password protected file on a
thumbnail drive by the researcher for a minimum of five years after the publication of
this study if needed for auditing (American Psychological Association, 2010).
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Chapter 4: Results
Introduction
The purpose of this study was to describe the multidimensional factors impacting
veterans’ HTN control. The purpose of this chapter was to present the overall results. It
begins with a data management brief, proceed to a description of the study results
according to research aims and questions. It concludes with a summary of the most
significant result of the study.
Data Management
Prior to statistical analysis, the researcher reviewed inclusion and exclusion
criteria and screened out five ineligible electronic medical records. This resulted in a
final sample size of 326. Accuracy of the data was not randomly checked due to
financial and time constraints during the data collection period. Consequently, an
interrater reliability of Cohen’s Kappa index was not calculated as originally planned.
Since the researcher was the only person who has extracted data in a consistent manner,
an intra-class correlation (ICC) would not be indicated.
Description of the Study Results
Aim # 1.
Describe the characteristics of hypertensive veterans in one Southern California
VA clinic from data collected during a period of October 17, 2014 through October 17,
2016.
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Question # 1.
What were characteristics of hypertensive veterans in one Southern California VA
clinic for the seven dimensions of IVs from data collected during a period of October 17,
2014 through October 17, 2016?
The study sample had most cases (80.4%) between the ages of 45 and 76 years
old with Mage = 62 and SD = 13. Most were male veterans (95.4%) diagnosed with
essential HTN and comorbidities, including dyslipidemia (68.4%) with HDL level at 33
mg/dl in most cases, obesity (56.7%) with BMI of 30 kg/m2 in most cases, and diabetes
(45.4%) with A1C level at 5.5 mg/dl in most cases. A large portion of cases (37.1%) had
no service-connected disability rating, despite documented ratings for the remaining
cases with M = 40% and SD = 40%. Nearly one-half (47.9%) of cases were diagnosed
with OSA, one-third (32.8%) with MDD, 20.9% with PTSD, and 12.9% with GAD.
Most cases (70.9 %) were Christians, including 27% Roman Catholics and 43.9% nonCatholic Christians. Most cases (90.1%) served in either the U.S. Navy (63.1%) or U.S.
Army (28.2%) during the Vietnam war/Korean war/World War II (47.6%). Most cases
did not use tobacco (79.4%) or consume alcohol (87.8%). Approximately one-third of
cases (36.5%) had an average of five to eight healthcare visits at a Southern California
primary care or cardiology clinic, averaging two to four visits per year from October 17,
2014 through October 17, 2016. Most cases (42.6%) received only one antihypertensive
medication with ACE inhibitors (38.3%), beta blockers (34.4%) and calcium channel
blocker (30.7%) comprised the top three most commonly prescribed antihypertensive
medications at the time of EMR review from October 17, 2016 to November 15, 2016.
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While rates of pre-HTN rose from 43.6% to 55.5%, Stage I HTN decreased from 30.4%
to 16.3% during two-year study period. Rates of Stage I HTN at baseline were 43.3%, at
the final measurement were 21.2%, and the 2-year SBP control rate was 42%. Tables 1-3
provide a summary of the characteristics of HTN veterans in this Southern California
primary care clinic.
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Table 1
Demographic Characteristics of Hypertensive Veterans in a Southern California Primary
Care Clinic
N
%
Age (in years) M = 62, SD = 13, Median = 63, Mode = 68

326

100.0

24 – 44

31

9.5

45 – 64

144

44.2

65+

151

46.3

Sex (Male)

311

95.4

200

61.3

African American

68

20.9

Asian and Other

44

13.5

88

27.0

143

43.9

12

3.7

Air Force

28

8.6

Army

92

28.2

Navy

204

62.5

Peace Time Only

69

21.2

Persian Gulf War

102

31.3

Vietnam Era/Korean War/WW II

155

47.6

≥ High School

115

35.3

< High School

5

1.5

Race/Ethnicity (missing 14 = 4.3%)
Caucasian

Religion (missing 83 = 25.5%)
Roman Catholic
Non-Catholic Christians
Others
Branch of Military Service (missing 2 = 0.6%)

Time Periods of Military Service

Education (missing 206 = 63.2%)
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Table 2
Medical History of Hypertensive Veterans in a Southern California Primary Care Clinic
N

%

Current Tobacco Use

67

20.6

Current Alcohol Use
Obstructive Sleep Apnea

43
156

13.2
47.9

185

56.7

Overweight (25 - 29.9)

103

31.6

Dyslipidemia
HDL (mg/dl) M = 43.8, SD = 15, Median = 40, Mode = 33

223

68.4

150
83

46.0
25.5

50 – 59
≥ 60

45

13.8

39

12.0

Missing

9

2.8

209

64.1

6.5 – 8.4

79

24.3

≥8.5

18
20

5.5
6.1

148

45.4

107

32.8

42
68

12.9
20.9

Brain (stroke, transient ischemia attack)

19

5.8

Heart (heart failure, coronary artery disease, heart attack, CABG)
Kidney (chronic kidney disease)

57
36

17.5
11.0

No Disability Rating

121

37.1

10-50% Disability Rating
60-100% Disability Rating

76
129

23.3
39.6

Lifestyle

Comorbidity
Obesity (BMI ≥30)
BMI (kg/m2) M = 31, SD = 6, Median = 30, Mode = 30

< 40
40 – 49

A1C (mg/dl) M = 6.3, SD = 1.3, Median = 6, Mode = 5.5
<6.5

Missing
Diabetes Milieus Diabetes
Mental Health Disorder
Major Depressive Disorder
Generalized Anxiety Disorder
Post-Traumatic Stress Disorder
Target Organ Damage

Service-Connected Disability (%) M = 40, SD = 40, Median = 30 Mode = 0
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Table 3
Hypertensive-Related Data for Study Veterans in a Southern California Primary Care
Clinic
Parameter
N
%
Medications
Self-Reported Medication Non-Adherence

24

7.4

0 visit in 2-year

18

5.5

1-4 visits in 2-year

104

31.9

5-8 visits in 2-year

119

36.5

≥9 visits in 2-year

85

26.1

0 BP RX

25

7.7

1 BP RX

139

42.6

2 BP RX

104

31.9

3+ BP RX

58

17.8

1-5 medications

96

29.4

6-10 medications

118

36.2

11-15 medications

86

26.4

≥ 16 medications

25

7.7

Baseline SBP (120-139 mmHg)

142

43.6

Final SBP (120-139 mmHg)

181

55.5

Two-year uncontrolled SBP (October 17, 2014 – October 17, 2016)

189

58.0

Clinic visits (visit/2-year) M = 6, SD = 4, Median = 6, Mode = 5

BP medication class (M = 1.6, SD = 1, Median = 1, Mode = 1)

All medications (M = 8.56, SD = 4.6, Median = 8, Mode = 5)

Baseline SBP (mmHg) M = 137, SD = 18, Median = 138, Mode = 138
Final SBP (mmHg) M = 130, SD = 15, Median = 130, Mode = 132
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Aim # 2.
Examine the relationships among the predictor variables of blood glucose level
(A1C), high-density lipoprotein (HDL), body mass index (BMI), number of BP
medication prescribed, number of clinic visits, baseline SBP, and the outcome variable of
the final point SBP.
Question # 2a.
Which of the possible six predictor variables were included in an equation for
predicting veterans’ final point SBP?
Answer # 2a.
Prior to conducting a stepwise MLR analysis, data was screened for missing
values and outliners. The process led to an elimination of 25 outlier cases based on a
Mahalanobis distance ≤ 22.458 at P <0.001. Normality was assessed by visual inspection
of histogram (see Figure # 5-8) and skewness, kurtosis per descriptive statistics (see
Figure 9). This process led to transformation of four variables A1c, HDL, BMI, BaSBP.
Homoscedasticity was accessed by tolerance statistics and VIF with all IV indices > 0.1
and VIF indices < 10 (see Figure 10) and residual plots without major clusters (see
Figure 11) indicated no homoscedasticity problems. Linearity was assessed between IVs
and DV with transformed data by scatter and residual plots (see Figure 12).
Only one out of six predictor variables could be included in the prediction model.
The other five (A1c, HDL, BMI, BP drug class and clinic visit) could not be included in
the prediction model due to a severe violation to linearity assumption of the MLR model
with non-elliptical shaped scatter plots (see Figure 12), an indication for non-linear
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correlations between IVs and DV or disconnected scores from the center mean line
without a rectangular formation on the residual plot (see Figure 11). At this point, a
decision was made to abandon the MLR analysis for a concern that forcing it may
produce a false or biased result.
Question # 2b.
Does the obtained regression equation resulting from a subset of the six predictor
variables allow us to reliably predict veterans’ final point SBP?
Answer # 2b.
After eliminating five predictor variables from the MLR equation, baseline SBP
was the only predictor variable left in the prediction model and it did not allow us to
reliably predict veterans’ final point SBP.
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Figure 5. Histogram of A1C
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Figure 6. Histogram of HDL
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Figure 7. Histogram of BMI
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Figure 8. Histogram baseline SBP
Descriptive Statistics
A1c
N

Valid

HDL

BMI

Baseline SBP

306

318

326

326

20

8

0

0

Mean

6.337

43.80

31.16

138.71

Median

6.000

40.00

30.00

138.00

5.5

33

30

138a

1.3086

14.969

6.001

19.838

1.982

1.916

.914

.825

.139

.137

.135

.135

4.961

7.203

1.164

1.861

.278

.273

.269

.269

Missing

Mode
Std. Deviation
Skewness
Std. Error of Skewness
Kurtosis
Std. Error of Kurtosis

Figure 9. Skewness and kurtosis of 4-variable
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Unstandardized
Model
1

B

Std. Error

95.0% CI for B
Sig.

L. Bound

U. Bound

Collinearity Statistics
Tolerance

VIF

-93.128

34.914

.008

-161.841

-24.415

>0.1

<10

lg10A1c

-3.073

10.961

.779

-24.645

18.499

.928

1.077

lg10HDL

3.622

6.671

.588

-9.506

16.751

.853

1.173

lg10BMI

15.819

10.757

.142

-5.352

36.990

.870

1.150

lg10BaSBP

90.897

13.421

.000

64.485

117.309

.973

1.028

BP drug class

.784

.847

.355

-.883

2.452

.951

1.051

Clinic Visit

.100

.222

.652

-.337

.538

.960

1.041

(Constant)

Figure 10. Tolerance and VIF

Figure 11. Residual plots
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Figure 12. Scatterplots for Question # 2a
Aim # 3.
Describe any significant association among non-normally distributed IVs and the
final SBP.
Question # 3.
Can status of veterans’ final SBP be correctly predicted from knowledge age,
A1C, HDL, BMI?
Answer # 3.
Since total BP med and clinic visit were normally distributed variables per
histograms and descriptive statistics, they were not included in the LR model testing.
Age was added to the LR model analysis instead.
Forward stepwise LR analysis was conducted to explore which of the four (age,
A1C, HDL, BMI) were predictors of veterans’ final SBP (controlling for alcohol use, all
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medication and anxiety statistically). Regression results indicated that the overall model
fit was good with -2 Log likelihood = 405.969 compared to -2 Log likelihood = 748.595
capable of predicting membership reliably (Mertler & Vannatta, 2013). However, none
of the four IVs were entered at the step one of the forward LR model, indicated that there
was not any significant correlation among them.
Aim # 4.
Describe any relationships between categorical predictor variables (Yes/No) and
an outcome variable of final (SBP < 140) or (SBP ≥140).
Question # 4.
What were the significant relationships between age (≥60 or <60), race
(Black/non-Black), religion (yes/no), tobacco use (yes/no), alcohol use (yes/no), OSA
(yes/no), DM (yes/no), dyslipidemia (yes/no), BMI (≥30, <30), MDD (yes/no), GAD
(yes/no), PTSD (yes/no), medication adherence (yes/no), brain damage (yes/no), heart
damage (yes/no), CKD (yes/no) and final SBP (≥ 140, < 140)?
Answer # 4.
χ2 tests were conducted to determine any relationships between 15 nominal
independent variables and the outcome variable. There was a strong evidence
(p < 0.001) to indicate that 1 of the 15 predictor variables (i.e., self-reported medication
adherence) was significantly associated with veterans’ final SBP (see Table 4).
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Table 4
Relationships between Categorical Independent Variables and Final SBP
Variable
χ2
p
Cramer’s V
Fisher’s Exact Test

Age (≥60/<60)

0.002

.960

.003

Race (Black/non-Black)

0.477

.490

.041

Religion (yes/no)

0.651

.722

.047

Tobacco use (yes/no)

0.004

.949

.004

Alcohol use (yes/no)

0.168

.682

.024

OSA (yes/no)

0.276

.600

.030

DM (yes/no)

0.036

.850

.011

BMI (≥30/<30)

1.058

.304

.059

MDD (yes/no)

1.106

.303

.059

GAD (yes/no)

0.013

.910

.007

PTSD (yes/no)

0.052

.478

.122

Med-adherence (yes/no)

80.921

< .001**

.586

Brain damage (yes/no)

1.495

.221

.070

Heart damage (yes/no)

3.385

.066

.106

Kidney damage (yes/no)

0.036

.850

.011
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Medication Adherence & Final SBP Chi-Square Tests
Asymptotic
Significance (2-

Exact Sig.

Exact Sig.

Point

df

sided)

(2-sided)

(1-sided)

Probability

103.373a

2

.000

.000

Likelihood Ratio

83.754

2

.000

.000

Fisher's Exact Test

80.921

.000

.000

Value
Pearson Chi-Square

21.868b

Linear-by-Linear

.000
1

.000

.000

Association
N of Valid Cases

301

a. 3 cells (50.0%) have expected count less than 5. The minimum expected count is 1.24.
b. The standardized statistic is -4.676.

Figure 13. X2 test / Fisher’s exact test
The X2 test result of medication adherence (yes/no) and SBP (≥140/<140) shows
that 3 cells = 50% which is ≥20% have expected count less than 5 with a standardized
statistic of -4.667 (<1), indicating an assumption violation. Fisher’s exact test was used
to interpret the test result.
Symmetric Measures
Value
Nominal by Nominal

Approximate

Exact

Significance

Significance

Phi

.586

.000

.000

Cramer's V

.586

.000

.000

N of Valid Cases

301

Figure 14. Cramer’s V
Summary of Results
Utilizing a convenient sample of 331 cases to represent hypertensive veterans in
the Southern California region, data was collected to explore multidimensional factors
impacting veterans’ HTN control. The study found a strong evidence (p < .001) to
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support that self-reported medication adherence to antihypertensive drugs was an
independent predictor to veterans’ final SBP level.
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Chapter 5: Discussion
The purpose of this chapter is to provide rich discussion to the study results. It
begins with a summary discussion of the research design and methodology that impact
the study results. It then compares these results with previous results in the area. It next
discusses the study limitations. It ends with implications for future research and a
conclusion.
Summary of Research Design and Method
This was the first study that utilized a VA dashboard data set in an EMR system
to explore multidimensional factors impacting U.S. veterans’ final SBP. The unique
research design allowed the study to provide novel insights into multiple aspects of HTN
control research results for future studies. First, the descriptive statistics demonstrated a
long term (2-year) uncontrolled SBP rate of 58% and an increased pre-HTN rate of
11.9% from a baseline point 43.6% to a final point of 55.5% of an EMR review. Second,
the fitness test of exploratory MLR model showed five unfitted variables including A1C,
HDL, BMI, BP med, clinic visit due to severe normality and or linearity violations. The
unfitting variable of A1C and HDL could be associated to manipulations by DM and
dyslipidemia medication therapy, making values of A1C and HDL atypical. The
exploratory stepwise LR model showed a good overall model fit, no significant
correlations were found between four IVs (i.e., age, A1C, HDL, Baseline SBP) and one
DV (SBP), suggesting none of the four IVs from this data set were predictors for
veterans’ final SBP. Since A1C represents ones’ average blood sugar level within past
3-month, values of A1C must match with SBP measurements in the same time periods to
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have meaningful correlational outcomes. However, that was not the case in this study.
The exploratory χ2 tests showed 14 out of 15 non-significant associations between and
among independent variables (i.e., OSA, DM, dyslipidemia, MDD, GAD, PTSD, brain
damage, heart damage, CKD) and a dependent variable of final SBP. This is likely
associated with utilizing ICD-9-CM codes that only have “yes/no” options in operational
definition of many multidimensional variables by nature of utilizing retrospective data.
Surprisingly, the study found strong evidence (p < .001) of self-reported medication
adherence as an independent predictor for veterans’ final SBP based on a positive Fisher
exact test. Third, the cross-sectional data collection took place at a single point in time
per study case and the researcher could easily over or under estimate the results,
particularly in the estimation of regularly changing medication data. Fourth, the
retrospective EMR review utilized pre-existing data for a research purpose that was
unintended when the data was created. Nevertheless, the study had to employ available
data to answer four research questions by this inquiry. In this case, the results were less
robust than desired. Finally, the non-probability sampling method disqualified the study
for inferential statistics by design. However, multiple parallel comparisons of
characteristics of this study sample with characteristics of the previous study sample have
demonstrated a high external validity of the study results.
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Comparison of Study Results
Aim # 1.
Describe the characteristics of hypertensive veterans in one Southern California
VA clinic from data collected during a period of October 17, 2014 through October 17,
2016.
Question # 1.
What were characteristics of hypertensive veterans in one Southern California VA
clinic for the seven dimensions of IVs from data collected during a period of October 17,
2014 through October 17, 2016?
Per HTN control conceptual framework (see Figure 2), the demographic
dimension included age, sex, race, religion, branch of service, time of service, education,
and disability rating. The result of this study with Mage = 62 and SD = 13 was consistent
with a previous study results that showed veterans of multiple states with Mage = 63.9 and
SD = 13.2 (Fletcher et al., 2012) and a study result that showed non-veterans at a
Southern Florida Family Clinic with Mage = 62 and SD = 13 (Koti & Roetzbeim, 2015).
This study’s Mage was also consistent with the HTN-age prevalence in the United States
based on an epidemiological study by Yoon, Fryar, and Carroll (2015). Gender of this
study with 95.4% male was consistent with several previous HTN studies among VA
populations (Range 92% - 96%; Choma, Griffin, Kaltenbach, Greevy, & Rumine, 2012;
Fletcher et al., 2012; Gosmanova, Lu et al., 2014; Gosmanova, Molnar et al., 2015).
Results of race (61.3% Caucasian) was consistent with a previous HTN study
(Rittmueller et al., 2015), and the proportion of African-Americans (20.3%) of this study
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was consistent with another previous HTN study result (Gosmanova, Molnar et al.,
2015). However, education background of this study was missing in 64.7% of the cases;
yet multiple similar HTN studies reported no such information. Results of religion,
branch of military service, time of military service, and service connected disability have
become major strengths of this study as the combined information allowed for a more
complete picture of veterans’ wellbeing from multiple perspectives. Spiritually, this
study shows 71% of cases were Christians, including 27% Roman Catholics and 43.9%
non-Catholic Christians compared with 69% Christians in the United States (Religion,
2016). Socioeconomically, this study shows the plurality of cases (43.6%) were Vietnam
veterans with most of whom were from lower working class backgrounds with three
fourths had family incomes above the poverty level (Sobering Vietnam Vets as of April
2016). Functionally, this study shows 37% cases without any service-connected
disability ratings compared with previous HTN studies that had no such information
reported. Results of multiple parallel comparisons indicated a well-represented
demographic dimension with additional strengths to the study.
Per HTN control conceptual framework (see Figure 2), the lifestyle dimension
included tobacco use and alcohol abuse. This study shows 20.6% current tobacco and
13.2% current alcohol users, consistent with a previous study results with 22% selfreported smoker and 11% positive screen for mild alcohol misuse by AUDIT-C
(Rittmueller et al., 2015). Results of the parallel comparison of two studies indicate a
well-represented sampling in the lifestyle dimension.
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Per HTN control conceptual framework (see Figure 2), the secondary HTN
dimension included an OSA diagnosis. This study shows 47.9% OSA among studied
cases compared with 29% of mild and 30% of moderate OSA among hypertensive nonveterans’ cases in a primary care setting (Brostrom et al., 2012), indicating more veterans
in the study than non-veterans in a previous HTN study suffered OSA. Since OSA is
associated with metabolic syndrome (Kong et al., 2016) with much higher prevalence
rates of dyslipidemia, obesity, and insulin resistance rates among veterans (Fryar et al.,
2016), it is possible that veterans would have also experienced a much higher rate of
OSA than civilian population. The parallel comparison of two studies indicates a much
higher OSA cases in the study compared with a previous study of civilian counterpart
(Brostrom et al., 2012).
OSA represents a common, treatable, metabolic syndrome significantly associated
with obesity, dyslipidemia and insulin resistance (Kong et al., 2016). One component of
treatment for OSA is weight loss; therefore, perhaps the time has come to debate
instituting a policy that holds patients accountable for their healthcare providers’
recommendations. Specifically, this policy could detail healthcare providers’ rights in
situations where the patient does not demonstrate efforts to lose weight, refuses to discuss
weight loss options, or does not wear continuous positive airway pressure (CPAP)
machine at night based on the treatment providers’ best judgement. Current health policy
lacks a balanced approach in the long-term management of OSA, emphasizing patients’
rights and satisfactions, but no responsibilities for one’s own behavioral choices.
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Per HTN control conceptual framework (see Figure 2), a total of three sets of
major CVD comorbidities and lab values were included in the dimension. The study
shows 68.4% dyslipidemia which was higher compared with a previous HTN study
results of 56.6% (Fryar et al., 2016). This study shows 56.7% obesity which was also
higher compared with a previous HTN study result of 41.2% (Fryar et al., 2016). This
study shows a median BMI of 30 compared with a previous HTN study result that
showed median BMI of 28.2 to 31.5, depending on group assignment by age (Choma et
al., 2012). The study also shows 45.4% DM which is much higher compared with a
previous HTN study result that showed 16.4% among male veterans in the U. S. from
2009 to 2012 (Fryar et al., 2016). Additionally, this study result shows median A1C of 6
mg/dl compared with a previous HTN study result that showed median A1C 7.0-7.2
mg/dl depending upon group assignments by age (Choma et al., 2012). The parallel
comparison of two studies indicates a well-represented sampling in cardiovascular
comorbidities of HTN (dyslipidemia and obesity) with exception of DM as there were
more DM cases in the study than in the previous study. Cases of DM in this study were
better controlled than cases in the previous study. No parallel comparison study could be
found for the HDL laboratory value in the literature.
Per HTN control conceptual framework (see Figure 2), the mental health
dimension included three mental health diagnosis. This study shows 32.8% MDD which
is consistent with a previous HTN study result that showed 32.5% (Wecht et al., 2016).
This study shows 12.9% GAD which is much lower than the previous HTN study result
that showed 25% (Wecht et al., 2016). This study shows 20.9% PTSD which is
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consistent with a previous HTN study result that showed 20% (Wecht et al., 2016). The
parallel comparison of two studies indicates a well-represented sampling of mental health
diagnosis in MDD and PTSD.
Per HTN control conceptual framework (see Figure 2), the medication dimension
included medication adherence, an average of two-year clinic visit, number of BP
medication patients were receiving, top three BP medication prescription names and a
mean overall prescription medications patients were receiving at the time of data
collection. This study shows a self-reported non-adherence rate of 7.4%, a much lower
rate than a previous HTN study result that showed ≥ 20% medication non-adherence rate
(Meddings et al., 2012). The result of two-year primary and cardiology clinic visit M
±SD = 6±4, averaging 3±2 per year is consistent with a previous HTN study result that
showed M±SD = 4.5±2 (Koti & Roetzbeim, 2015). This study shows 7.7% cases
received no BP medication, 42.6% received one, 31.9% received two and 17.8% received
three or more BP medications, consistent with a previous HTN study results that showed
41.6% received one, 26.9% received dual and 15.9% received three or more BP
medications (Vincze et al., 2008). A trend of the highest percentage of cases receiving
monotherapy might indicate that 42.6% cases of this study and 41.6% cases of the
previous HTN study were being treated for stage 1 rather than stage 2 HTN per JNC-7
HTN treatment guideline. In addition, this study shows the top three commonly
prescribed antihypertensive medications were ACE inhibitor 38.3%, beta blockers 34.4%,
and calcium channel blockers 30.7% compared with a previous HTN study that showed
diuretic 45%, ACE inhibitors 37.5%, and calcium channel blockers 35% in an orthostatic
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hypotensive group (Wecht et al., 2016) vs. ACE inhibitor 35.5%, calcium channel
blockers 29%, and diuretics 27.4% in an orthostatic hypertension group (Wecht et al.,
2016). Nevertheless, BP drug class makes no difference in reducing CVD risks among
hypertensive cases based on a credible systematic review and meta-analysis (Frethim et
al., 2012). However, JNC-7 recommended monotherapy with diuretic for most
(Chobanian et al., 2003) without a sound of scientific evidence. This study shows a
bimodal (see Figure 15) distribution in the total number of overall medications with two
peaks at 5 and 10 indicating most study cases took either 5 or 10 kinds of prescription
medications per day, a phenomenon of polypharmacy. Unfortunately, the bimodal shape
of the total number of overall medications prevented the variable from participating in
both MLR and LR analysis due to a concern that the data might bring about false or
biased results. However, a previous HTN study result that showed “a higher number of
prescribed medication (sr2 = 0.06, t = 2.42, p <.05) and lower medication adherence (sr2 =
0.07, t =-2.60, p <.05) were statistically significant determinants” of an increased SBP
among Chinese American immigrants (Li, Wallhagen, & Froelicher, 2010). Results of
the parallel comparisons indicate a well-represented sampling in total number of clinic
visit and BP medication, but not medication adherence and total number of an overall
medication in the medication dimension.
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Figure 15. Bimodal distribution
Per HTN control conceptual framework (see Figure 2), the uncontrolled HTN
dimension included baseline and final SBP as well as end-organ damage. Despite sevenpoint mean SBP decrease from the baseline 58% to the final point of 42%, the study
shows a lower long term (two-year) SBP control rate of 42% (see Table 1) compared
with the HTN control rate of 61.2%, a goal set by the Healthy People 2020 (Gillespie &
Hurvitz, 2013). The study shows 11.9% increase in pre-HTN cases from a baseline
(43.6%) to a final point (55.5%) of an EMR review (z = 3.2897, p<.001).
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JNC-7 highlighted that “pre-hypertensive individuals require health promoting
lifestyle modifications to prevent the progressive rise in BP and cardiovascular disease”
(Chobanian et al., 2003, p. xiv) because risk for CVD doubles in increments of 20/10
mmHg beginning at 115/75 mmHg (Chobanian et al., 2003). Nurse practitioners with the
best training in health promotion and disease prevention are well positioned to provide
counseling services to patients for lifestyle changes if deemed to be necessary. However,
literature indicates that healthcare providers are not reimbursed for time spent on
addressing lifestyle issues in patients with pre-hypertension (Hernandez & Anderson,
2012). This problem needs to be resolved at the federal level to include these services in
Medicare and Medicaid coverage.
This study shows HTN-associated brain damage in 5.8% study cases compared
with a previous HTN study results that showed 4.2% to 4.5% depending upon a BP
treatment goal (“JATOS,” 2008), heart damage (17.5%) compared with the previous
HTN study results (5.4% to 11.8%) depending upon levels of alcohol consumption
(Rittmueller et al., 2015) and kidney damage (11%) compared with the JATOS Study
Group results that showed 9.8% to 10% (2008) at a baseline.
In summary, multiple parallel or non-parallel comparisons of this study’s
characteristics with prior studies helps to determine an external validity of an overall
research results. Primarily, this study’s results could be generalizable to the target
population of U.S. veterans given that the sample’s characteristics are highly
representative of this group in terms of age, gender, ethnicity, lifestyle factors,
comorbidities, mental health diagnosis and BP medication classes.
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Aim # 2.
Examine the relationships among the predictor variables of blood glucose level
(A1C), high-density lipoprotein (HDL), body mass index (BMI), total number of BP
medication prescribed, total number of clinic visits, baseline SBP and the outcome
variable of the final point SBP.
Question # 2a.
Which of the possible six predictor variables (i.e., A1C, HDL, BMI, clinic visit,
BP med class, baseline SBP) were included in an equation for predicting veterans’ final
point SBP?
Question # 2b.
Does the obtained regression equation resulting from a subset of the six predictor
variables allow us to reliably predict veterans’ final point SBP?
Five out of six predictor variables were excluded from the MLR model due to
severe linearity violations to the model assumption. As such, baseline SBP was the only
predictor variable remaining in the MLR prediction model. Since veterans’ SBP
fluctuated throughout the day and can also be affected by confounders of lifestyle (e.g.,
alcohol, diet, exercise, caffeine, stress) and medication factors, a single baseline SBP
would not have allowed us to predict veterans’ final SBP reliably as multiple confounders
were unaccounted by the prediction model. There are other factors that could have
impacted A1C’s model fitness. First, A1C values lack variance when most (64.1%) DM
cases were well controlled by medication therapy as evidenced by A1C mode = 5.5 mg/dl
and kurtosis = 4 .961, making it unfit to the prediction model with severe linearity
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violation to the MLR model assumption. Second, A1C represents an average of blood
sugar level in the past three months and it must be associated with final SBP
measurements within the same time periods for a meaningful outcome. However, that
was not the case in this study.
While there is no evidence of a study examining an association between HDL and
SBP in the literature, this study failed to find any association between the two variables.
Nevertheless, HDL mode = 33 mg/dl was well below the normal values of ≥ 40 mg/dl for
men and ≥ 50 mg/dl for women, this could indicate that HDL values are difficult to
change with or without medication therapy. Moreover, HDL Kurtosis = 7.203 was unfit
to a normal bell curve due to a severe violation to MLR model assumption. The nonlinear association between HDL and SBP based on scatter plots (see Figure 12) was
another violation to MLR model assumption. Although no evidence of a study
examining the association, a previous HTN study found a positive association (p < 0.01)
between the ratio of total cholesterol (TC) to HDL or TC/HDL and BP alternatively
(Okosun, Choi, Hash, & Dever, 2001).
While no evidence of a study examining an association between number of clinic
visits and SBP, this study failed to detect any association between the two variables due
to a severe violation of linearity assumption to the MLR model. While a previous
systematic review and meta-analysis found no significant differences between BP
medication class and BP reduction for primary prevention of DVD (Frethim et al., 2012),
this study failed to detect any association between the two variables due to a severe
violation of linearity assumption to the MLR model.
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Aim # 3.
Describe any significant association between and among non-normally distributed
IVs and the final SBP.
Question # 3.
Can status of veterans’ final SBP be correctly predicted from knowledge of age,
A1C, HDL, BMI?
Considering the review of relevant literature that found no statistically significant
association between age and SBP, this study failed to detect it despite a previous
epidemiology study showing an evidence that a relationship between age and SBP did
exist (Yoon et al., 2015). Considering a previous systematic review and meta-analysis
which found a weak linear association between BMI and SBP (Abayomi, 2012), this
study failed to detect it in a LR model analysis. Failing to detect BMI and SBP
association could be attributed to the strength of R2 values that ranged from 0.083 (weak)
for males to 0.203 (weak) for females in the meta-analysis (Abayomi, 2012) with a good
overall LR model fit background. Although weak associations could be detected with a
high power by increasing a sample size, it was not the case in this study.
Aim # 4.
Describe any relationships between categorical predictor variables (Yes/No) and
an outcome variable of final controlled (SBP < 140) or uncontrolled (SBP ≥140).
Question # 4.
What were the significant relationships between age (≥60 or <60), race
(black/non-black), religion (yes/no), tobacco use (yes/no), alcohol use (yes/no), OSA
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(yes/no), DM (yes/no), dyslipidemia (yes/no), BMI (≥30, <30), MDD (yes/no), GAD
(yes/no), PTSD (yes/no), medication adherence (yes/no), brain damage (yes/no), heart
damage (yes/no), CKD (yes/no) and final SBP (≥ 140, <140)?
This study shows a strong evidence (P<0.001) that self-reported medication
adherence is an independent predictor for veterans’ SBP. These results support a
previous HTN study that showed habit-based medication adherence was not only the
most effective predictor for BP outcomes, but also the most effective intervention in
reducing BP by a systematic review and meta-analysis (Con, Ruppar, & Chase, 2016).
Although age 60 is a cut off point for a new set of BP treatment goals per JNC-8
(James et al., 2013), this study shows no significant association between age (≥60 / <60)
and SBP (≥ 140 / <140). Still, 60 seem to be an age of high HTN prevalence in multiple
epidemiology studies. However, it is the inferential statistics showing a statistically
significant association between age and SBP with a p-value (<0.05) that matters. So far,
there is no previous study with a finding of a significant association between age and BP
in the literature.
This study shows no significant association between race (black / non-black) and
SBP (≥ 140 / <140), inconsistent with a previous systematic review that showed a small
effect size, but significant association between perceived racial discrimination among
hypertensive black males with low education level and HTN (Dolezsar, McGrath, Herzig,
& Miller, 2014).
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This study shows no significant association between religion (yes / no) and SBP
(≥ 140 / <140) compared with a previous study that showed religious service attendance
is inversely associated to SBP among white, black and Mexican-American ethnic groups
(Bell et al., 2012). There is no systematic review and or meta-analysis exploring a
relationship between religious involvement and SBP to the best of my knowledge.
This study shows no significant association between tobacco use (yes / no) and
SBP (≥ 140 / <140), consistent with a previous cross-sectional study that showed
tobacco use had no effect on BP (Li et al., 2010; Pandey et al., 2014; Thuy et al., 2010).
However, there is no systematic review and or meta-analysis exploring an association
between tobacco use and SBP to the best of my knowledge.
This study shows no association between alcohol use (yes / no) and SBP (≥ 140,
<140) compared with a previous systematic review and meta-analysis that showed an
association between dose-response alcohol consumption and risk of HTN (Briasoulis et
al., 2012). Specifically, drinking alcohol <10 gm/day to 11-20 gm/day has a trend toward
an increased risk of HTN (RR 1.03, 95% CI, 0.94 -1.13, p = 0.51) and (RR 1.15, 95% CI,
0.99-1.33, p = 0.06) respectively, and that men with heavy drinking of alcohol at 31- 40
gm/day is significantly associated with an increased risk of HTN (RR 1.77, 95% CI, 1.392.26, P<0.001). However, that systematic review and meta-analysis demonstrated an
inclusion of articles defining HTN as BP ≥ 165/95 mmHg rather BP ≥ 140/90 mmHg,
which was inconsistent with the JNC-7 guideline.
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This study shows no association between OSA (ye s/ no) and SBP (≥ 140 /
<140), consistent with a reviewing of relevant literature that found no association
between OSA and BP by systematic review and or meta-analysis to the best of my
knowledge.
This study shows no association between DM (yes / no) and SBP (≥ 140 / <140),
consistent with a review of relevant literature that found no association between DM and
BP by systematic review and or meta-analysis to the best of my knowledge.
This study shows no association between dyslipidemia (yes / no) and SBP (≥ 140
/ <140), consistent with a review of relevant literature that found no association between
dyslipidemia and BP by systematic review and or meta-analysis to the best of my
knowledge.
This study shows no association between BMI (≥30 / <30) and SBP (≥ 140 /
<140), inconsistent with findings from two previous HTN studies that showed BMI was
not only significantly and positively associated with SBP and DBP (Zhang, Wang, Yan,
Gong, & Guo, 2013), but also linearly or curvilinearly associated with SBP by a metaanalysis despite the relationship was rather weak (Abayomi, 2012).
This study shows no association between MDD (yes / no) and SBP (≥ 140 /
<140), consistent with a review of relevant literature that found no association between a
diagnosis of MDD and SBP to the best of my knowledge.
This study shows no association between GAD (yes / no) and SBP (≥ 140 /
<140), inconsistent with a previous systematic review and meta-analysis result that
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showed a significant association between anxiety and HTN with OR 1.18, 95% CI, 1.02
to 1.37, P < 0.001 (Pan et al., 2015).
This study shows no association between PTSD (yes / no) and SBP (≥ 140 /
<140), consistent with a review of relevant literature that found no association between
PTSD diagnosis and SBP to the best of my knowledge.
This study shows a strong evidence (P<0.001) of self-reported medication
adherence to antihypertensive medication (yes / no) and is an independent predictor to
veterans’ SBP (≥ 140 / <140), inconsistent with a review of relevant literature that found
no systematic review and or meta-analysis exploring such a relationship to the best of my
knowledge. Therefore, the finding of such a significant association could be viewed as
innovative and the result must be confirmed by systematic review and or meta-analysis
utilizing RCT and longitudinal studies in the future. However, current medication
adherence construct lacks an association with BP control outcome which makes it
difficult to associate two variables of medication adherence and BP in one entity.
Clearly, there is a need for an operational definition of patients’ adherence to
antihypertensive medication that are associated with BP outcomes in one entity.
Finally, this study shows no association between brain damage (yes / no), or heart
damage (yes / no) or kidney damage (yes / no) and SBP (≥ 140 / <140), inconsistent
with two previous Japanese study results that showed brain damage, or heart damage or
kidney damage were significantly associated with SBP (“JATOS,” 2008; Ogihara et al.,
2010). However, this Japanese study did have serious methodological weaknesses. It
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would be better if evidence of significant associations between and among brain, heart,
kidney damages and SBP were found from a couple of systematic review and or metaanalysis, however such evidence was not found by this review of relevant literature.
Comparing this study results that utilized MLR, LR and X2 statistical analysis
models with previous HTN study results via systematic review and or meta-analysis may
seem to be unparalleled. However, this is the best way for truth finding if researchers
want the most efficient way about it. First, systematic review and or meta-analysis are
research designs with the highest level of study quality (Crowther, Lim, & Crowther,
2010). Second, systematic review and or meta-analysis produces results with less biases
(Crowther et al., 2010) compared with results from cross-sectional studies.
Limitation
There are several limitations to this study. First, there were noteworthy issues
with the operational definition of key study variables including A1C, tobacco
dependence, alcohol abuse or misuse, MDD, GAD, PTSD, OSA, DM, dyslipidemia,
Obesity, CVA, TIA, CHF, CAD, MI, CABG and CKD, resulting in an inadequate
assessment of correlations between these variables and final SBP. Future studies should
pay attention to the special features of A1C values and consider using validated
multidimensional instruments in relationship studies. Specifically, ensuring A1c values
matches BP measurements within three-months window time frame for meaningful
correlational outcomes is important. Moreover, using patients’ Health Questionnaire
(PHQ-9; Kroenke, Spitzer, & Williams, 2001) for assessing MDD, Generalized Anxiety
Disorder scale (GAD-7; Plummer, Manea, Trepel, & McMillan, 2016) for GAD, and
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PCL-5-M (Keane et al., 2014) for PTSD are more meaningful than using ICD-9-CM
codes with “yes / no” operational definition in relevant relationship studies. Second,
there were major barriers to data accuracy assessment regarding primary data
manipulation and data collection. Specifically, primary data of A1C and HDL values
were manipulated by medication therapy for approximately 96.3% veterans and the
impact of manipulation to the overall statistical model fit was difficult to estimate.
Additionally, funding and time constraints prohibited random check blindly on collected
data. Consequently, the inter-rater agreement Kappa was not calculated to confirm the
accuracy of the data collected.
Implication for Future Research
Although this study finds self-reported medication adherence is an independent
predictor to a veteran’s final SBP level, validity of self-reported medication adherence
can be influenced by multidimensional factors including patients-related factors (e.g.,
age, sex, race, education level, knowledge, self-care ability, patient-satisfaction, selfefficacy, attitude, cognition, perceived stress), provider-related factors (e.g., prescription
of medication, communication style, attitude toward adhering to current HTN treatment
guideline, role modeling, teaching consistency and content) and environment-related
factors including health policy (e.g., insurance, copayment, BP treatment goal per HTN
management guideline) and healthcare system (e.g., access to care, communication
system) (Viswanathan et al., September 2012). Therefore, future HTN control research
should focus on multidimensional determinants of self-reported patients’ adherence to
antihypertensive medications fully. Since all medications have side effects in context
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that some patients are not on antihypertensive medication therapy for treatment of HTN
and that lifestyle modification works for BP reduction (Briasoulis et al., 2012;
Landsbergis et al., 2013; Mesas, Leon-Munoz, Rodriguez-Artalejo, & Lopez-Garcia,
2011; Saneei et al., 2014; Semlitsch et al., 2013), future HTN research should focus on
multidimensional determinants of self-reported patients’ adherence to HTN treatment
fully to broaden the scope of coverage. Since current definition of patients’ adherence
to HTN treatment lacks an association with HTN outcomes based on extensive review of
relevant literature, future HTN control research should focus on operationally defining
adherence and BP control outcomes in one entity. Since HTN definition can affect HTN
control outcomes, future HTN control study should use a consistent HTN definition
defined by JNC-7 rather than JNC-8. Since self-reported HTN treatment may be
influenced by not only patients, but also healthcare providers, future HTN control studies
should assess this construct for both patients and healthcare providers simultaneously so
that two-way outcome feedback could be accomplished. Since theory can help to make
predictions of ones’ BP levels possible (Bandura, 1971) when an operational definition of
patients’ adherence to HTN treatment is defined with BP outcome in one entity, future
HTN control research should focus on some theory-guided operational definitions linking
patients’ adherence to HTN treatment and outcomes (e.g., primary, secondary and or
tertiary).
Ideally, patients’ adherence to HTN treatment should be assessed by a scaled
measure that takes into consideration multidimensional factors impacting BP control
rather than self-reported adherence utilizing “yes/no” options when it can be quickly and
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easily done in the real world. However, it may subject veterans’ to recall bias and
reading level. Therefore, future theory guided operational definitions of self-reported
adherence to HTN treatment will be challenged by these limitations. It is therefore,
vitally important to consider using the future tense in the sentence construction and
reading level with some theory-guided operational definitions linking patients’ and
providers’ adherence to HTN treatment and outcomes. Multiple field tests and pilot
studies would be necessary in the process of developing a reliable theory-guided
instrument measuring self-reported patients’ and providers’ adherence to a standardized
HTN treatment protocol in the future.
Since the rate of pre-HTN increased from the baseline to final point per EMR
review, associating risks of pre-HTN with CVD or benefit with pre-HTN could also
guide future research. Since current research is not only limited on the topic, but also
with multiple methodological weaknesses in the research design based on a review of
relevant literature, utilizing a random sampling method in longitudinal studies to explore
any relationships would be helpful in contributing potential new knowledge to the
existing nursing research database.
Conclusion
The study explored multidimensional factors impacting veterans’ HTN control
with a descriptive, exploratory, cross-sectional, retrospective and non-probability
sampling design. Despite the limited data in essential areas, the study found a strong
evidence (p<0.001) through fisher exact test to support that self-reported medication
adherence to antihypertensive medication therapy was an independent predictor to
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veterans’ final SBP. Future HTN control research may focus on exploring some theoryguided multidimensional determinants of patients’ and providers’ adherence to HTN
treatments (e.g., lifestyle modification and antihypertensive drug therapy), rather than
unidimensional medication adherence, and HTN control outcomes fully (e.g., BP, quality
of life, target organ damage), utilizing a consistent HTN definition defined by JNC-7.
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Appendices
Appendix A: SPSS Code for
Exploring Factors Impacting Veterans’ Hypertension Control
Variable

Variable Description

Measure

1. Age

Index date per EMR review
(≥60, <60) for χ2 test.

Continuous,
Categorical,
Dichotomous
Continuous
&
Categorical,
Continuous
&
Categorical,

2. DisRat

3. A1C

Disability rating by
percentage of service
connected disability
HgA1C (mg/dl)

4. HDL

HDL (mg/dl)

Continuous
&
Categorical,

5. BMI

BMI (kg/m2)

Continuous
&
Categorical,

6. BPRX

Total number of BP
medication prescription at
the time of EMR review

Continuous
&
Categorical,

7. AmT

All medication total

Continuous
&
Categorical,

Total number of primary &
cardiology clinic visit

Continuous
&
Categorical,

8. ClinVist

Values
1 = 24 – 44,
2 = 45 – 64,
3 = 65+
0 = 0 %,
1 = 10 - 50%,
2 = 60 - 100%,
0 = < 6.5,
1 = 6.5 – 7.4
2 = 7.5 – 8.4,
3 = 8.5 -9.4
4 = ≥ 9.5,
99 = missing
1 = < 40,
2 = 40-49
3 = 50-59,
4 = ≥ 60
999= missing
0 = 18.5-24.9,
1 = 25.0-29.9
2 = 30.0-34.9,
3 = 35.0-39.9
4 = ≥ 40.0
0 = 0 BP RX
1 = 1 BP RX
2 = 2 BP RX
3 = ≥ 3 BP RX
1 = 1-5 pills
2 = 6-10 pills
3 = 11-15 pills
4 = ≥16 pills
0 = 0 visit in 2-year
1 = 1-4 visits in 2-year
2 = 5-8 visits in 2-year
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9. BaSBP

during the 2-year study
period
Baseline systolic BP at the
time of EMR review

3 = ≥ 9 visits in 2-year
Continuous
&
Categorical,

10. BaDBP

Baseline diastolic BP at the
time of EMR review

Continuous
&
Categorical,

11. FiSBP

Final systolic BP at the time
of EMR review

Continuous
&
Categorical,

12. FiDBP

Final diastolic BP at the
time of EMR review

Continuous
&
Categorical,

13. Sex

Men or Women

Nominal

14. Race

Race/Ethnicity of case

Nominal

15. Religion

Religious affiliation of cases

Nominal

16. Branch

Branch of military serviced

Nominal

17. Time

Time periods of service

Nominal

18. Edu

Highest education level
attained

Ordinal

current smoke/chew tobacco
per MD’s note/ICD-9-CM
code

Nominal

19. Tobacco

0 = < 120,
1 = 120-139
2 = 140-159,
3 = ≥160
0 = < 80,
1 = 80-89
2 = 90-99,
3 = ≥100
0 = < 120,
1 = 120-139
2 = 140-159,
3 = ≥160
0 = < 80,
1 = 80-89
2 = 90-99,
3 = ≥100
1 = Men,
2 = Women
1 = Caucasian
2 = African American
3 = Other or missing
1 = Roman Catholic
2 = Non-Catholic Christian
3 = other or missing
1 = Air Force,
2 = Army
3 = Navy
0 = Peace time only
1 = Persian Gulf War
2 =Vietnam Era/Korean
war/WW II
1 = < High School,
2 = ≥ High School,
99 = missing
0 = no
1 = yes
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20. Alcohol

current drink alcohol per
ICD-9-CM code & MD’s
note
MDD per ICD-9-CM code
GAD per ICD-9-CM code
PTSD per ICD-9-CM code
OSA per ICD-9-CM code
ACE inhibitor
Angiotensin Receptor
Blocker
α-blocker (Prazosin)
BB (Atenolol)
CCB (Amlodipine,
diltiazem, Verapamil,
Nifedipine)
Centrally acting α-Agonist
Combination drugs
Diuretic
Vasodilator/hydralazine
Spironolactone
Nitrates/Isosorbide
Medication adherence

Nominal

0 = no
1 = yes

Nominal
Nominal
Nominal
Nominal
Nominal
Nominal

0 = no, 1 = yes
0 = no, 1 = yes
0 = no, 1 = yes
0 = no, 1 = yes
1 = Yes, 0 = No
1 = Yes, 0 = No

Nominal
Nominal
Nominal

1 = Yes, 0 = No
1 = Yes, 0 = No
1 = Yes, 0 = No

Nominal
Nominal
Nominal
Nominal
Nominal
Nominal
Nominal

Nominal
Nominal

0 = no, 1 = yes

39. EODkidney
40. Dyslip
41. DM
42. FinalSBP

EOD-brain:
TIA/CVA/dementia
EOD-heart
CHF/CAD/MI/CABG
Chronic kidney disease
(CKD)
Dyslipidemia
HTN comorbidity of DM
For LR analysis

1 = Yes, 0 = No
1 = Yes, 0 = No
1 = Yes, 0 = No
1 = Yes, 0 = No
1 = Yes, 0 = No
1 = Yes, 0 = No
0 = Medication Nonadherence
1 = Medication Adherence
99 = missing
0 = no, 1 = yes

Nominal

0 = no, 1 = yes

Nominal
Nominal
Dichotomous

43. FinalDBP

For LR analysis

Dichotomous

0 = no, 1 = yes
0 = no, 1 = yes
0 =≥ 140
1 = < 140
0 = ≥ 90
1 = < 90

21. MDD
22. GAD
23. PTSD
24. OSA
25. ACEI
26. ARB
27. α-block
28. BB
29. CCB

30. CAαA
31. ComDrug
32. Diuretic
33. HydraZin
34. Spiro
35. Iso
36. MedAdh

37. EOD-brain
38. EOD-heart
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Appendix B: Data Abstraction Instrument (Microsoft Excel in Word Format)

ID

1

2

3

4

5

6

7

Age

DisRat

A1C

HDL

BMI

BPmT

AmT

A0097,RIC

ID

8

9

10

11

12

13

14

ClinVist

BaSBP

BaDBP

FiSBP

FiDBP

Sex

Race

15

16

17

18

19

20

21

Religion

Branch

Time

Edu

Tobacco

Alcohol

MDD

22

23

24

25

26

27

28

GAD

PTSD

OSA

ACEI

ARB

a-Block

BB

29

30

31

32

33

34

35

CCB

CAaA

CombDrug

Diuretic

HydroZin

Spiro

Iso

B0245,ROG

ID
C0051,ROC

ID
D0583,LAR

ID
E1605,LIS

ID
F1586,JAM

36

37

38

39

40

41

42

MedAdhe

EODbrain

EODheart

EODkidney

Dyslip

Obesity

DM
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Appendix C: Theoretical and Operational Definition of Key Study Concept
Age: is defined by the date of birth (DOB) on the day of an EMR review.
Sex: is categorized by male or female per EMR review.
Race/ethnicity: is classified as Caucasian, African American, Other or missing per EMR
review.
Religion: is classified by Roman Catholic, non-Catholic Christian, Other or missing per
EMR review.
Branch of military service: is classified as Air Force, Army or Navy per EMR review.
Time periods of military service: is classified as Peace time only, Persian Gulf war,
Vietnam Era / Korean war / WW II per EMR review.
Education: is classified as ≥ high school or missing or < high school based on
multidisciplinary “note” per EMR review.
Service connected disability: is operationally measured from 0 to 100% per EMR
review.
Current tobacco use: is operationally measured by presence (yes) or absence (no) of
tobacco dependence ICD-9-CM code 305.1 and primary healthcare providers’ “note”
indicating current use per EMR review.
Current alcohol use: is operationally measured by presence (yes) and absence (no) of
alcohol abuse ICD-9-CM code 305.00 and primary healthcare providers’ “note”
indicating current consumption of alcohol per EMR review.
OSA: is operationally measured by presence (yes) or absence (no) of OSA ICD-9-CM
code 327.23 per EMR review.
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DM: including type I and II, is operationally measured by presence (yes) or absence (no)
of DM ICD-9-CM code 250.00 per EMR review.
A1C: referring to an average blood sugar level for the past three months, is operationally
measured by the latest (toward the end of a EMR review) A1C (mg/dl) value from
October 17, 2014 through October 17, 2016 per EMR review.
HDL: referring to a high-density lipoprotein level, is operationally measured by the latest
(toward the end of chart review) HDL value (mg/dl) from October 17, 2014 through
October 17, 2016 per EMR review.
Dyslipidemia: referring to an abnormal blood lipid level, is operationally measured by
presence (yes) or absence (no) of dyslipidemia ICD-9-CM code 272.4 per EMR review.
BMI (body mass index): is operationally measured by the latest measurement (toward
the end) from Oct 17, 2014 through Oct 17, 2016 per EMR review.
MDD (major depressive disorder): is operationally measured by presence (yes) or
absence (no) of MDD ICD-9-CM code 298.0 per EMR review.
GAD (generalized anxiety disorder): is operationally measured by presence (yes) or
absence (no) of GAD ICD-9-CM code 300.02 per EMR review.
PTSD (post-traumatic stress disorder): is operationally measured by presence (yes) or
absence (no) of PTSD ICD-9-CM code 309.81 per EMR review.
BP medication: is operationally measured by a numeric number from 0 – 4 of BP
medication class among ACEI, ARB, α-blocker, β-blocker, CCB, centrally acting αagonist, Combination drug, Diuretic, Vasodilator, Spironolactone and Nitrates case per
EMR review.
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Clinic Visit: is operationally measured by a numeric number from 0 – 15 primary care
and cardiology clinic visits during a period of October 17, 2014 and October 17, 2016
based upon the total number of BP measurements generated from those office visits.
Baseline and final BP measurement: are continuous variable in “mmHg” by toward the
beginning and toward the end of the EMR review from October 17, 2014 through
October 17, 2016.
Essential HTN: is operationally defined as BP elevation without identifiable cause with
seated BP ≥ 140/90 mmHg at two or more office visits or current use of BP-lowering
medication with ICD-9-CM code of 401 regardless their awareness of it (Chobanian et
al., 2003; James et al., 2013).
Controlled HTN: is operationally defined as BP < 140/90 mmHg at both the baseline
and the final points of a EMR review.
Uncontrolled HTN: is operationally defined as BP ≥ 140/90 mmHg at both the baseline
and the final points of a EMR review.
Medication adherence: is operationally measured by primary healthcare providers’ note
(e.g., patient was non-adherent to antihypertensive drug therapy, or patient refused to
antihypertensive drug therapy) per EMR review.
End organ damage of brain: is operationally measured by presence (yes) or absence
(no) of TIA, CVA and dementia ICD-9-CM code of 433.1 for TIA, 434.91 for CVA and
290.42 for vascular dementia per EMR review.
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End organ damage of heart: is operationally measured by presence (yes) or absence
(no) of CHF CAD, MI, CABG ICD-9-CM codes of 428.0 for CHF, 414.01 for CAD,
410.9 for MI and V45.81 for CABG per EMR review.
End organ damage of kidney: is operationally measured by presence (yes) or absence
(no) of CKD ICD-9-CM code of 585.9 per EMR review.
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Appendix D: IRB Approval Form from the University of San Diego
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